{"globalData": [{"username": "admin", "data": {"courses": [{"name": "Course1", "contentCourse": [{"name": "chapter1", "contentChapter": [{"id": 0, "contentCard": {"Q": "Comment vous-appelez vous ?", "A": "Admin"}}, {"id": 1, "contentCard": {"Q": "Que faites vous ?", "A": "J'utilise un programe g\u00c3\u00a9nial!"}}, {"id": 2, "contentCard": {"Q": "Que faites vous ?", "A": "J'utilise un programe g\u00c3\u00a9nial!"}}]}]}, {"name": "Cours 3", "contentCourse": [{"name": "chapitre 1", "contentChapter": [{"id": 4, "contentCard": {"Q": "testasde", "A": "testdzq"}}, {"id": 5, "contentCard": {"Q": "tezsfs", "A": "bgeber"}}, {"id": 3, "contentCard": {"Q": "testfcs\nfreinjjead\nferc", "A": "Warning: QT_DEVICE_PIXEL_RATIO is deprecated. Instead use:\n   QT_AUTO_SCREEN_SCALE_FACTOR to enable platform plugin controlled per-screen factors.\n   QT_SCREEN_SCALE_FACTORS to set per-screen factors.\n   QT_SCALE_FACTOR to set the application global scale factor."}}, {"id": 4, "contentCard": {"Q": "buhj k", "A": "yjgvb"}}, {"id": 5, "contentCard": {"Q": "rgae", "A": "grea"}}]}]}, {"name": "csdc", "contentCourse": [{"name": "gerdzdv", "contentChapter": [{"id": 0, "contentCard": {"Q": "tesree", "A": "tedsfs"}}, {"id": 1, "contentCard": {"Q": "grtfvd c fvd", "A": "gerfdvc dcsx"}}]}, {"name": "hrtbrtgfvfd", "contentChapter": [{"id": 0, "contentCard": {"Q": "br", "A": "feds vefsd"}}, {"id": 1, "contentCard": {"Q": "vdqs", "A": "vdwcx"}}]}, {"name": "grfbtgfcds", "contentChapter": [{"id": 0, "contentCard": {"Q": "", "A": ""}}, {"id": 1, "contentCard": {"Q": "fearqcd", "A": "freaccq"}}]}]}, {"name": "cdsazs", "contentCourse": [{"name": "kujhnrtfgb", "contentChapter": [{"id": 0, "contentCard": {"Q": "frecsd", "A": "farecqd"}}, {"contentCard": {"Q": "fzfokd,so, \nfze k,", "A": "fz,kell,kefz \nfz k"}}, {"contentCard": {"Q": "vzdskl, ", "A": "cdsk,l"}}]}, {"name": "gertdvfbvgf", "contentChapter": []}]}, {"name": "hytger", "contentCourse": []}, {"name": "hthegrrfdc", "contentCourse": []}, {"name": "nfterfdvd", "contentCourse": [{"name": "tetr", "contentChapter": [{"id": 0, "contentCard": {"Q": "etret", "A": "trtry"}}, {"id": 1, "contentCard": {"Q": "t(rrt", "A": "gttr"}}]}]}, {"name": "jygerfvfdc", "contentCourse": []}, {"name": "yukujh", "contentCourse": [{"name": "hrtgbfvc", "contentChapter": [{"id": 2, "contentCard": {"Q": "vdfc x", "A": " swdzs\nfedqcs"}}, {"id": 3, "contentCard": {"Q": ",okll", "A": "bhjn "}}]}, {"name": "jhngb  vedfv", "contentChapter": []}, {"name": "nhtgb v", "contentChapter": [{"id": 0, "contentCard": {"Q": "bdxgrs\nbfsv \nvfqdwc", "A": "brzfs gresvd greaf vrges\ngzrer \ngrezg raeg  \"re"}}, {"id": 1, "contentCard": {"Q": "greg vvf", "A": "gzevf gre\ngrefvdqd"}}]}]}, {"name": "ngvh,uyfthng", "contentCourse": []}, {"name": "modifi\u00e9", "contentCourse": [{"name": "chapitre modifi\u00e9", "contentChapter": []}, {"name": "un espace", "contentChapter": []}, {"name": "deux  espaces", "contentChapter": []}, {"name": "espace 1", "contentChapter": []}]}, {"name": "testFormat", "contentCourse": [{"name": "testFormatV2", "contentChapter": [{"id": 0, "contentCard": {"Q": "rouge normal nt(object) passed as parameter. type() function is mostly used for debugging purposes.\nTwo different types of arguments can be passed to type() function, single and three argument. If single argument type(obj) is passed, it returns the rouge gras rouge vert-gras", "A": "vert-soulign\u00e9 Les sections suivantes d\u00e9crivent les types standards int\u00e9gr\u00e9s \u00e0 l'interpr\u00e9teur.\nLes principaux types natifs vert sont les num\u00e9riques, les s\u00e9quences, les dictionnaires, les classes, les instances et les exceptions.\nrouge-gras. Normal."}, "format": {"Q": [["r"], ["r"], ["r"], ["r"], ["r"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["r"], ["r"], ["r"], ["r"], ["r"], [], ["b"], ["b"], ["b"], ["b"], [], ["r"], ["r"], ["r"], ["r"], ["r"], ["b"], ["b", "g"], ["b", "g"], ["b", "g"], ["b", "g"], ["b", "g"], ["b", "g"], ["b", "g"], ["b", "g"], ["b", "g"]], "A": [["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["g"], ["g"], ["g"], ["g"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], [], [], [], [], [], [], [], [], []]}}, {"id": 1, "contentCard": {"Q": "mauve normal", "A": "gras rouge mauve normal"}, "format": {"Q": [["p"], ["p"], ["p"], ["p"], ["p"]], "A": [["b", "g"], ["b", "g"], ["b", "g"], ["b", "g"], ["b", "g"], ["r"], ["r"], ["r"], ["r"], ["r"], 1, ["p"], ["p"], ["p"], ["p"], ["p"]]}}, {"id": 2, "contentCard": {"Q": "rouge-gras Some operations are supported by several object types; in particular, practically all objects can be compared for equality, tested for truth value, and converted to a string (with the repr() function or the slightly different str() function). vert-soulign\u00e9 The latter function is implicitly used when an object is written by the print() function. rouge", "A": "vert sauf indication contraire. rouge-gras vert (Exception importante : les op\u00e9rations bool\u00e9ennes or et and renvoient toujours l'une de leurs op\u00e9randes.) rouge"}, "format": {"Q": [["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], 168, ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], 68, ["u"], ["u"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], ["u", "g"], 91, ["r"], ["r"], ["r"], ["r"], ["r"]], "A": [["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"], 26, ["g", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], 1, ["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"], 39, ["g", "h"], ["g", "h"], 66, ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"]]}}, {"id": 3, "contentCard": {"Q": "rouge-gras I'm iterating over a list of tuples in Python, vert rouge-soulign\u00e9 and am attempting to remove them if they meet certain criteria. vert", "A": "vert-barr\u00e9 Most answers on this page don't really rouge-soulign\u00e9-gras explain why removing elements while iterating over a list produces strange results,vert but th  rouge"}, "format": {"Q": [["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], 48, ["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"], ["u"], ["u"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], 41, ["u"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u"], 18, ["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"]], "A": [["s", "g"], ["s", "g"], ["s", "g"], ["s", "g"], ["s", "g"], ["s", "g"], ["s", "g"], ["s", "g"], ["s", "g"], ["s", "g"], ["b", "r"], ["b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["g"], ["g"], ["g"], ["g"], ["g"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["g"], ["g"], ["g"], ["g"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"]]}}, {"id": 4, "contentCard": {"Q": "The answers vert-barr\u00e9 suggesting list comprehensions are ALMOST correct -- ROUGE-SOULIGNE except that they build a completely new list and then give it gras the same name the vert old list as, they do NOT rouge-gras", "A": "vert Note the subtle difference with other rouge answers: this one is NOT assigning to a barename - it's assigning to a rouge-gras list slice that just happens to be the soulign\u00e9 entire list, vert-italique"}, "format": {"Q": [12, ["s", "g", "h"], ["s", "g", "h"], ["s", "g", "h"], ["s", "g", "h"], ["s", "g", "h"], ["s", "g", "h"], ["s", "g", "h"], ["s", "g", "h"], ["s", "g", "h"], ["s", "g", "h"], ["r"], 15, ["r"], 14, ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["u", "r", "h"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["b"], ["b"], ["b"], ["b"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"]], "A": [["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"], 39, ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], 71, ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], 40, ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], 13, ["i", "g", "h"], ["i", "g", "h"], ["i", "g", "h"], ["i", "g", "h"], ["i", "g", "h"], ["i", "g", "h"], ["i", "g", "h"], ["i", "g", "h"], ["i", "g", "h"], ["i", "g", "h"], ["i", "g", "h"], ["i", "g", "h"], ["i", "g", "h"], ["i", "g", "h"]]}}]}, {"name": "testhighlight", "contentChapter": [{"id": 0, "contentCard": {"Q": "surlign\u00e9 soulign\u00e9 rouge surlign\u00e9-vert-gras", "A": "surlign\u00e9-rouge normal"}, "format": {"Q": [["b"], ["b"], ["b"], ["b"], 1, ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], 1, ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["b"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"], ["b", "g", "h"]], "A": [["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"]]}}, {"id": 1, "contentCard": {"Q": "surlign\u00e9 gras normal surlign\u00e9-rouge", "A": "surlign\u00e9-rouge-soulign\u00e9-gras-italique normal normal gras vert-surlign\u00e9"}, "format": {"Q": [["h"], ["h"], ["h"], ["h"], ["h"], ["h"], ["h"], ["h"], 1, ["b"], ["b"], ["b"], ["b"], 7, ["r"], ["u", "r"], ["u", "r"], ["u", "r"], ["u", "r"], ["u", "r"], ["u", "r"], ["u", "r"], ["u", "r"], ["u", "r"], ["u", "r"], ["u", "r"], ["u", "r"], ["u", "r"], ["u", "r"]], "A": [["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], ["u", "i", "b", "r", "h"], 8, ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], 1, ["b", "h"], ["b", "h"], ["b", "h"], ["b", "h"], 1, ["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"], ["g", "h"]]}}, {"id": 2, "contentCard": {"Q": "rouge normal surlign\u00e9-barr\u00e9", "A": "normal gras gras-italique surlign\u00e9-rouge-gras"}, "format": {"Q": [["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], 8, ["s"], ["s"], ["s"], ["s"], ["s"], ["s"], ["s"], ["s"], ["s"], ["s"], ["s"], ["s"], ["s"], ["s"]], "A": [7, ["b"], ["b"], ["b"], ["b"], ["b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"], ["i", "b", "r", "h"]]}}]}, {"name": "testpurple", "contentChapter": [{"id": 0, "contentCard": {"Q": "mauve normal mauve-gras", "A": "rouge mauve-soulign\u00e9 normal mauve-gras-italique"}, "format": {"Q": [13, ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"]], "A": [["r"], ["r"], ["r"], ["r"], ["r"], 1, ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], 8, ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"], ["i", "b"]]}}, {"id": 1, "contentCard": {"Q": "mauve normal", "A": "gras rouge mauve normal"}, "format": {"Q": [["p"], ["p"], ["p"], ["p"], ["p"]], "A": [["b"], ["b"], ["b"], ["b"], 1, ["r"], ["r"], ["r"], ["r"], ["r"]]}}, {"id": 2, "contentCard": {"Q": "mauve", "A": "mauve-soulign\u00e9 normal rouge"}, "format": {"Q": [["p"], ["p"], ["p"], ["p"], ["p"]], "A": [["u", "p"], ["u", "p"], ["u", "p"], ["u", "p"], ["u", "p"], ["u", "p"], ["u", "p"], ["u", "p"], ["u", "p"], ["u", "p"], ["u", "p"], ["u", "p"], ["u", "p"], ["u", "p"], 8, ["r"], ["r"], ["r"], ["r"], ["r"]]}}]}]}, {"name": "studyTest", "contentCourse": [{"name": "testsFormats", "contentChapter": [{"id": 0, "contentCard": {"Q": "normal rouge rouge-gras-barr\u00e9 normal surlign\u00e9 gras", "A": "normal vert-gras  surlign\u00e9-barr\u00e9-soulign\u00e9"}, "format": {"Q": [["u"], ["u"], ["u"], ["u"], ["u"], ["u"], 1, ["r"], ["r"], ["r"], ["r"], ["r"], ["b", "r"], ["s", "b", "r"], ["s", "b", "r"], ["s", "b", "r"], ["s", "b", "r"], ["s", "b", "r"], ["s", "b", "r"], ["s", "b", "r"], ["s", "b", "r"], ["s", "b", "r"], ["s", "b", "r"], ["s", "b", "r"], ["s", "b", "r"], ["s", "b", "r"], ["s", "b", "r"], ["s", "b", "r"], ["s", "b", "r"], 8, ["h"], ["h"], ["h"], ["h"], ["h"], ["h"], ["h"], ["h"], 1, ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"]], "A": [6, ["b"], ["b", "g"], ["b", "g"], ["b", "g"], ["b", "g"], ["b", "g"], ["b", "g"], ["b", "g"], ["b", "g"], ["b", "g"], 1, ["u", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"], ["u", "s", "h"]]}}, {"id": 1, "contentCard": {"Q": "gras surlign\u00e9-rouge gras surlign\u00e9-barr\u00e9 coucou tu veux voir ma bite", "A": "mauve normal mauve-gras-surlign\u00e9 normal surlign\u00e9-rouge"}, "format": {"Q": [["b"], ["b"], ["b"], ["b"], ["r"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], 1, ["b"], ["b"], ["b"], ["b"], 1, ["h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"], ["s", "h"]], "A": [["p"], ["p"], ["p"], ["p"], ["p"], 7, ["b"], ["b", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], ["b", "h", "p"], 7, ["r"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"]]}}, {"id": 2, "contentCard": {"Q": "test du mode \u00e9tude-rouge-gras un mot-surlign\u00e9-soulign\u00e9-vert", "A": "normal mauve-barr\u00e9 surlign\u00e9-rouge normal gras-rouge normal"}, "format": {"Q": [["u", "i"], ["u", "i"], ["u", "i"], ["u", "i"], ["u", "i"], ["u", "i"], ["u", "i"], ["u", "i"], ["u", "i", "h"], ["u", "i", "h"], ["u", "i", "h"], ["u", "i", "h"], ["u", "b"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u", "b", "r"], ["u"], ["u"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"], ["u", "g", "h"]], "A": [6, ["p"], ["s", "p"], ["s", "p"], ["s", "p"], ["s", "p"], ["s", "p"], ["s", "p"], ["s", "p"], ["s", "p"], ["s", "p"], ["s", "p"], ["s", "p"], ["r"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], ["r", "h"], 7, ["b"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"], ["b", "r"]]}}]}, {"name": "testformat2", "contentChapter": [{"id": 0, "contentCard": {"Q": "rouge normal surlign\u00e9 normal mauve", "A": "rouge-gras-surlign\u00e9 normal mauve-gras"}, "format": {"Q": [["r"], ["r"], ["r"], ["r"], ["r"], 8, ["h"], ["h"], ["h"], ["h"], ["h"], ["h"], ["h"], ["h"], 8, ["p"], ["p"], ["p"], ["p"], ["p"]], "A": [["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], ["b", "r", "h"], 1, ["h"], ["h"], ["h"], ["h"], ["h"], ["h"], ["b"], ["b", "p"], ["b", "p"], ["b", "p"], ["b", "p"], ["b", "p"], ["b", "p"], ["b", "p"], ["b", "p"], ["b", "p"], ["b", "p"]]}}, {"id": 1, "contentCard": {"Q": "blob", "A": "plouf"}, "format": {}}]}]}]}}, {"username": "randomUser", "data": {}}, {"username": "bernard", "data": {"courses": [{"name": "Physique", "contentCourse": [{"name": "Optique", "contentChapter": [{"id": 0, "contentCard": {"Q": "qu'est ce qu'un oeil", "A": "un oeil"}}, {"id": 1, "contentCard": {"Q": "ccze", "A": "ferez"}}, {"id": 2, "contentCard": {"Q": "grtge", "A": "reaz"}}, {"id": 3, "contentCard": {"Q": "grte", "A": "eryjuy"}}]}]}]}}, {"username": "david", "data": {"courses": []}}, {"username": "", "data": {"courses": []}}, {"username": "Chlo\u00e9", "data": {"courses": [{"name": "Rhumatologie", "contentCourse": [{"name": "M\u00e9tabolisme osseux", "contentChapter": [{"id": 0, "contentCard": {"Q": "Constitution tissu osseux", "A": "- cellules : ost\u00e9ocytes , ost\u00e9oblastes, ost\u00e9oclastes\n- eau\n- prot\u00e9ines : coll type I ++\n- +++ min\u00e9ral : hydroxyapatite"}, "format": {"Q": [["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"]], "A": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"]]}}, {"contentCard": {"Q": "Marqueurs biologiques de la r\u00e9sorption et de la formation osseuse", "A": "FORMATION\n- Phosphatase alcaline osseuse :  < ost\u00e9oblaste  (alternative : ost\u00e9ocalcine) \n- PINP  : \tpas de rythme circardien\n\taugm ++ lors d'un R/ ost\u00e9oformateur \n\nRESORPTION\n- CTX-1  : \tpeptide provenant clivage par ost\u00e9oclastes\n\trythme circadien avec pic seconde portion de la nuit et nadir l'apr\u00e8s midi \n\t-> dosage \u00e0 jeun : Glc diminue les taux circulants\n\t3 int\u00e9r\u00eats : \t- identifier pers. \u00e0 risque d'OP surtt imm\u00e9diatement apr\u00e8s MNP*\n\t\t- chute rapide (end\u00e9ans 6mois) apr\u00e8s mise en route \n\t\t\tR/ antir\u00e9sorbeur pr\u00e9dit : \n\t\t\t- augm ult\u00e9rieure de la masse osseuse\n\t\t\t- dim du risque fractureur \u00e0 2-3 ans\n\t\t\t- objective prise et bonne absorption du m\u00e9doc\n\t\t- dosage r\u00e9gulier apr\u00e8s arr\u00eat m\u00e9doc permet de d\u00e9cider ou non reprise R/\n\n* Au + taux CTX-I \u00e9lev\u00e9 , au + remodelage osseux rapide. \nReconstitution osseuse jamais strictement \u00e9quivalente \n-> chaque cycle fait perdre un peu de masse osseuse\n-> risque d'ost\u00e9op\u00e9nie + \u00e9lev\u00e9 \u00e0 terme si nombre de cycle + important"}}, {"contentCard": {"Q": "Maladies avec remodelage osseux accru", "A": "- Hyperparathyro\u00efdie primaire \n- Hyperthyro\u00efdie \n- Maladie de Paget \n- Acrom\u00e9galie \n- M\u00e9tastases osseuses \n"}}, {"contentCard": {"Q": "Maladie avec remodelage osseux diminu\u00e9 ", "A": "- hypothyro\u00efdie\n- hypopara \n- hypopituitarisme \n- d\u00e9ficit en hormone de croissance \n- insuffisance r\u00e9nale s\u00e9v\u00e8re : os adynamique"}}, {"contentCard": {"Q": "Causes d'\u00e9l\u00e9vation de la phosphatase alcaline osseuse", "A": "- Croissance et grossesse\n- Fractures (polytrauma) \n- Maladie de Paget\n- M\u00e9tastase osseuses \n- Ost\u00e9omalacie (carence en vit D3) \n\nuniquemement ds les formes s\u00e9v\u00e8res avec remodelage osseux acc\u00e9l\u00e9r\u00e9 : \n- Algodystrophie sympathie r\u00e9flexe \n- hyperparathyro\u00efdie \n- hyperthyro\u00efdie "}}]}, {"name": "Ost\u00e9oporose", "contentChapter": [{"id": 0, "contentCard": {"Q": "D\u00e9finition", "A": "Perte de masse osseuse et d\u00e9t\u00e9rioration de la microarchitecture osseuse (perte de connectivit\u00e9 entre les trav\u00e9es) \n-> diminuent la r\u00e9sistance m\u00e9anique du squelette \n-> augmentent donc le risque de fractures spontan\u00e9es ( = non traumatiques)  :  fractures survenant dans le d\u00e9cours d'un traumatisme \u00e9quivalent ou inf\u00e9rieur \u00e0 une chute de sa propre hauteur\n\nPerte osseuse associ\u00e9e \u00e0 l'OP porte sur - contenu min\u00e9ral, \n\t\t\t- trame prot\u00e9ique\n\nD\u00e9finition officielle  (par l\u2019OMS)   = mesure quantitative de la densit\u00e9 min\u00e9rale osseuse = DMO \n\nMAIS on consid\u00e8re aujourd\u2019hui que la r\u00e9sistance osseuse est due \n- autant \u00e0 la quantit\u00e9 d\u2019os (donc notamment au pic de masse osseuse acquis pendant la croissance) \n- qu\u2019\u00e0 sa qualit\u00e9,  qui d\u00e9pend de variables comme \n\t- la microarchitecture, \n\t- le degr\u00e9 de min\u00e9ralisation, \n\t- le taux de remodelage, \n\t- la pr\u00e9sence de microfractures, etc. \n\nPar ailleurs, les complications fracturaires de l\u2019OP d\u00e9pendent de : \n- la quantit\u00e9/qualit\u00e9 de l\u2019os \n- d\u2019\u00f4 facteurs en particulier les chutes (FF : benzodiaz\u00e9pines). "}}, {"contentCard": {"Q": "Etiologies OP secondaire 20%", "A": "!! Particuli\u00e8rement les exclure chez l\u2019homme ost\u00e9porotique. \n\nles + importantes \n- cortico\u00efdes \n- cushing\n- hyperpara\n- hypogonadisme chez l'homme\n- maladie infl chroniques\n\nMaladies endocriniennes \t- Hypercorticisme (maladie de cushing)\n\t\t- Hyperparathyro\u00efdie \n\t\t- Hyperthyro\u00efdie \n\t\t- Anorexie mentale \n\t\t- Am\u00e9norrh\u00e9e athl\u00e9tique (trop de sport)\n\t\t- Hypogonadisme \n\t\t- Hypopituitarisme \n\nCarence calcique chronique \t- Intol\u00e9rance au lactose (d\u00e9ficit en lactase) \n\t\t- Gastrectomie \n\t\t- Malabsorption \n\t\t- Coeliaquie \n\t\t- Alimentation pauvre en calcium \n\t\t- Hypercalciurie chronique \n\nM\u00e9dicaments/toxiques \t- Glucocortico\u00efdes  ++++\n\t\t- H\u00e9parine (traitement au long cours) \n\t\t- Anticonvulsivants \n\t\t- Analogues du LHRH \n\t\t- Inhibiteurs de l\u2019aromatase \n\t\t- Ethanol \n\t\t- Tabac \n\nMaladies h\u00e9matologiques \t- My\u00e9lome multiple \n\t\t- Mastocytose syst\u00e9mique \n\nMaladies inflammatoires \t- Arthrite rhumato\u00efde \n\t\t- Maladie de Crohn \n\nMaladies g\u00e9n\u00e9tiques \t- Ost\u00e9ogen\u00e8se imparfaite \n\nImmobilisation prolong\u00e9e \t- Apesanteur \n\t\t- Alitement prolong\u00e9\n\n"}}, {"contentCard": {"Q": "Physiopathologie  OP cortisonique ", "A": "Corticoth\u00e9rapie  = \u00e9tiologie la plus fr\u00e9quente, \n- particuli\u00e9rement chez l'homme et la femme MNO, \n- mais aussi chez la femme non MNP m\u00eame pour de petites doses de prednisolone. \n\nPhysiopath complexe : \n- d\u00e9ficit d'absorption intestinale du calcium, \n- r\u00e9sorption osseuse accrue \n- intoxication chronique des ost\u00e9oblastes ->  d\u00e9faut de formation osseuse. \n\nLa perte est surtout importante au cours des premi\u00e8res ann\u00e9es deR/"}}, {"contentCard": {"Q": "Etiologie OP primaire (80% des cas) \nFdR", "A": "- ++ pic de masse osseuse trop faible (d\u00e9termin\u00e9 GENETIQUEMENT) \n- perte des st\u00e9ro\u00efdes sexuels - brutale chez la femme \n\t\t- progressive chez l\u2019homme\n- processus de vieillissement des ost\u00e9oblastes  \n- diminution des taux de vitamine D3 active, \nen raison d\u2019un m\u00e9tabolisme interm\u00e9diaire moins performant. \n\nFdR :  patientes ++\n- m\u00e9narche tardive (> 15 ans) \n- et/ou une carence gonadique (MNP) pr\u00e9matur\u00e9e, \n- maigreur\n- s\u00e9dentarit\u00e9\n- Toxiques : alcoolo-tabagiques\n- apports calciques franchement insuffisants : carence chronique"}}, {"contentCard": {"Q": "Clinique ", "A": "PAS de douleur (sauf si fracture ou arthrose sec aux fractures) \n\nFRACTURES \n- tassement vert\u00e9bral\n- ext distale du radius = pouteau colles\n- col f\u00e9moral  = !! perte d'autonomie\n- hum\u00e9rus\n- fractures d'inssuff de r\u00e9sistance osseuse \n\nTASSEMENT VERTEBRAL apd de T5\n- D+ \tdorsale ou lombaire brutale, \n\tspontan\u00e9e ou dans le d\u00e9cours imm\u00e9diat d'un effort minime. \n\tsouvent violente \n\tirradie habituellement en ceinture vers le thorax et/ou l'abdomen. \n- Rigidit\u00e9 vert.  importante \n- Impotence fonctionnelle justifie souvent l'alitement. \n- Evolution\t++ favorable :  en 4 \u00e0 6 semaines, \u00e0 nv  asympto jusqu'au tassement suivant. \n\tDiminution de la taille\n \tApparition de d\u00e9formations rachidiennes (cyphose dorsale, lordose lombaire) \n\tDouleurs chroniques li\u00e9es \u00e0 l'arthrose \n- Peut passer inaper\u00e7u : pas rare de trouver des tassements dorsaux ou lombaires multiples sur une Rx de profil du thorax ou de l\u2019abdomen chez des patientes peu symptomatiques, ayant souffert de douleurs dorsales ou lombaires attribu\u00e9es erron\u00e9ment \u00e0 de l\u2019arthrose ou \u00e0 des \u00ab lumbagos \u00bb.\n- R/ \timmobilisation de qques jours- semaines, \n\t antalgiques \n\tcas s\u00e9v\u00e8res : port transitoire d'une contention orthop\u00e9dique (corset) \n\nFRACTURES D'INSUFFISANCE DE RESISTANCE OSSEUSE =  fractures \u00ab de stress\u00bb \n- Diff\u00e9rence avec fractures classiques : absence (ou le peu) de d\u00e9placement. \n- Localisations : os cortical (++ m\u00e9tatarsiens) \n\tos trab\u00e9culaire (pilon tibial, calcaneum, ailerons sacr\u00e9s, branche ischio- et ilio-pubienne)\n- Rx: visible apr\u00e8s 2-3sem"}}, {"contentCard": {"Q": "Diagnostic ", "A": "1. CLINIQUE : fracture\n2. OSTEODENSITOMETRIE et FRAX \n3. IMAGERIE : radiologie \n4. BIOLOGIE"}}, {"contentCard": {"Q": "Diagnostic Biologie ", "A": "Contr\u00f4le biologique s'impose lors de la d\u00e9couverte d'une OP pour\n- s'assurer de son caract\u00e8re primaire \n- la distinguer d'\u00f4 maladies m\u00e9taboliques osseuses, comme l'ost\u00e9omalacie. \n\nOP primaire : \n- calc\u00e9mie et phosphor\u00e9mie normales\n- taux s\u00e9rique de la phosphatase alcaline totale normal, sauf parfois dans le d\u00e9cours imm\u00e9diat d'une fracture. \n\nOP secondaire : \n- chercher +++ chez l'homme (hypogonadisme) et la femme jeune\n- se m\u00e9fier ++ OP associ\u00e9es  \u00e0 un haut remodelage osseux, avec des indices de r\u00e9sorption \u00e9lev\u00e9s, en dehors de la post- MNP imm\u00e9diate o\u00f9 le remodelage est significativement acc\u00e9l\u00e9r\u00e9.\n\n\n- CRP \n- H\u00e9mogramme \n- Cr\u00e9atinine \n- Ionogramme \u00e0 jeun incluant calc\u00e9mie et phosphor\u00e9mie \n- Electrophor\u00e8se des prot\u00e9ines s\"riques\n- Immuno\u00e9lectrophor!se du serum (urines) \n- Phosphatase alcaline s\u00e9rique totale (ou osseuse) \n- PINP \n- CTX-I \u00e0 jeun \n- 25-(OH)D3 \n\nDosages uniquement en cas de suspicion clinique d'OP secondaire\n- \u03b2-carot\u00e8ne\n- PTH\n- TSH\n- Cortisolurie\n- Testost\u00e9rone(chez l\u2019homme) \n\n"}}, {"id": 7, "contentCard": {"Q": "Diagnostic Radiologie", "A": "SIGNES TARDIFS : \napr\u00e8s r\u00e9duction >1/3 masse osseuse\n- Rar\u00e9faction de la trame osseuse vert\u00e9brale - avec hypertrophie des trav\u00e9es portantes - \n- Diminution de l'\u00e9paisseur des corticales\n\nPlus tardivement encore\n- enfoncements des plateaux vert\u00e9braux  \n- tassements vert\u00e9braux complets \n!!  A ce stade, exclure la malignit\u00e9 \n\n\nOP cortisonique :  cals osseux immatures (bandes de densification floue) \n\nIRM  : ost\u00e9olyse et remplacement complet du signal m\u00e9dullaire vert\u00e9bral normal  !!! INQUIETANT \n\nFractures \"de stress\" ou \"d'insuffisance de r\u00e9sistance osseuse\" ( ailerons sacr\u00e9s, pilon tibial, m\u00e9tatarsiens),\n-  parfois difficilement visibles en radiologie conventionnelle, \n- d\u00e9masqu\u00e9s par la scintigraphie osseuse. "}}, {"id": 8, "contentCard": {"Q": "Diagnostic Ost\u00e9odensitom\u00e9trie", "A": "Evuation tr\u00e8s pr\u00e9cise de la densit\u00e9 min\u00e9rale osseuse (DMO) \n-> les valeurs ainsi mesur\u00e9es refl\u00e8tent correctement le risque fracturaire \u00e0 chaque site mesur\u00e9. \n\nLocalisations : - Rachis lombaire (site essentiellement trab\u00e9ulaire), \n\t- Hanche (site mixte cortical/trab\u00e9culaire) \n\t- \u00e9ventuellement, Corps entier (site essentiellement cortical). \n\n+  :\t- irradiation faible\n\t- facile rapide reproductible\n\t- bonne sensibilit\u00e9 (bonne mesure quantitative)\n- : \t- pas de mesure qualitative des trav\u00e9es par ex\n\nComparaison des valeurs de DMO \u00e0 celles d'une population t\u00e9moin (distribution gausienne).\n- Z-score :  diff\u00e9rence en \u00e9cart-type par rapport aux sujets du m\u00eame sexe et du m\u00eame \u00e2ge) \n- T-score :  sujets jeunes du m\u00eame sexe (moyenne du pic de masse osseuse, atteint entre 25 et 35 ans-)\n\nD\u00e9finition de l'OMS : \nOP  \t T-score <= - 2,5\nOst\u00e9op\u00e9nie  \tT-score entre \u20131 et \u20132,5. \n\nL\u2019interpr\u00e9tation des r\u00e9sultats  :  PIEGES !  arthrose interapophysaire lombaire  : augmente, art\u00e9factuellement, les valeurs de DMO. \n\t-> si > 65 ans : densitom\u00e9trie de la hanche plus informative que crachis lombaire. "}}, {"contentCard": {"Q": "Diagnostic : Indications d'ost\u00e9odensitom\u00e9trie", "A": "- p\u00e9riode MNP\n- carence gonadique prolong\u00e9e, \n- R/ aux glucocortico\u00efdes,\n- hyperparathyro\u00efdie (une DMO basse contribue \u00e0 la d\u00e9cision chirurgicale chez un patient asymptomatique), l\n- opoth\u00e9rapie (surtout si la TSH est indosable), \n- suivi d'un traitement (pour appr\u00e9cier un gain de masse osseuse), \n- d\u00e9couverte d'une ost\u00e9op\u00e9nie radiologique et de d\u00e9formations vert\u00e9brales."}}, {"contentCard": {"Q": "FRAX", "A": "Plut\u00f4t que de tenir compte uniquement de la valeur de la DMO, il est clairement pr\u00e9f\u00e9rable de l\u2019int\u00e9grer dans un indice fracturaire, appel\u00e9 FRAX, qui prend en compte d\u2019autres variable \nIl tient compte \n- de la valeur brute de la DMO (en l\u2019occurrence mesur\u00e9e au niveau du col f\u00e9moral) \n- et de 11 autres param\u00e8tres (age, sexe, poids, taille, fracture ant, parents avec fract du hanche, tabac, glucort, PR, OP sec, alcool) \n\n-> d\u00e9termine le risque fracturaire \u00e0 10 ans (bien entendu en l\u2019absence de traitement) pour \n\t- le col f\u00e9moral \n\t- et l\u2019ensemble des sites dits \u00ab majeurs \u00bb : col f\u00e9moral, vert\u00e8bres, hum\u00e9rus, radius (poignet) . \n\nL\u2019\u00e9valuation du risque fracturaire temp\u00e8re l\u2019enthousiasme th\u00e9rapeutique chez les personnes tr\u00e8s \u00e2g\u00e9es qui, virtuellement toutes, souffrent d\u2019OP, au sens OMS du terme, en prenant en compte d\u2019autres facteurs, dont la long\u00e9vit\u00e9 r\u00e9siduelle. \n-> Ne pas R/pharmacologiquement une patiente de 90 ans dont le risque fracturaire est de 20 % \u00e0 10 ans !\n\tMais  lutter contre la sarcop\u00e9nie, \u00e9viter les chutes, etc. \nOn peut esp\u00e9rer que le remboursement des m\u00e9dications contre l\u2019OP d\u00e9pendra un jour de cet indice plut\u00f4t que de la valeur de DMO\n\n\n\n. "}}, {"contentCard": {"Q": "R/ pr\u00e9ventif", "A": "- Exercice \t \t- pdt la croissance ++\n\t\t- S ost\u00e9ocytes et r\u00e9duire ainsi la production de scl\u00e9rostine\n- Eviter tabac, alcool\n- Pr\u00e9vention des chutes PA : - obstacle,\n\t\t-  bzd, \n\t\t- sarcop\u00e9nie\n\t\t- dim vision\n- Apport calcique alimentaires suffisants (1,5 g de calcium \u00e9l\u00e9mentaire pendant l'adolescence)\n- Oestog\u00e8nes naturels \n- SERM :  RALOXIFENE \n\n- Suppl\u00e9ment calcique (1g de Ca \u00e9l\u00e9mentaire) \n- associ\u00e9 \u00e0 vit D3  (de l'ordre de 800 UI/j) \nMAIS mvs adh\u00e9sion \u00e0 la calcith\u00e9rapie , suppl\u00e9ment naturels jug\u00e9s trop caloriques, risque de lithiase faible\n\n-  Pr\u00e9vention OP glucort trop souvent n\u00e9glig\u00e9e :  \n-> prescrire au minimum un suppl\u00e9ment calcique et de la vitamine D3 (800 U/jour). \n-> si  DMO basse au d\u00e9part + fortes doses de glucocortico\u00efdes : pfs i traitement pr\u00e9ventif plus incisif par un bisphosphonate (vide infra). "}}, {"contentCard": {"Q": "R/ pr\u00e9ventif Oestrog\u00e8nes naturels", "A": "Pendant longtemps, la prise pendant 5 \u00e0 10 ans apr\u00e8s MNP consid\u00e9r\u00e9e comme le gold standard de la pr\u00e9vention\n= R/ anti-r\u00e9sorbeur :  \t- conserve la masse osseuse et la micro-architecture squelettique \n\t\t- r\u00e9duit l'incidence des fractures de hanche et de vert. \n Aujourd'hui NON : augm \t- le risque de cancer du sein \n\t\t- et le risque thromboembolique. \n\t-> Effet b\u00e9n\u00e9fique sur l\u2019os dor\u00e9navant consid\u00e9r\u00e9 comme side benefit. \nIndication restante : \tfemmes MNP avec sympt du climat\u00e9riques invalidants \n\t\t\t+ p\u00e9riode limit\u00e9e dans le temps. \n"}}, {"contentCard": {"Q": "R/ pr\u00e9ventif SERM ", "A": "= modulateurs s\u00e9lectifs des r\u00e9cepteurs \u0153strog\u00e9niques (SERM, selective estrogen- receptor modulators) \n - pr\u00e9viennent \u00e9galement la perte osseuse post-MNP. \n- activent s\u00e9lectivement certains types de r\u00e9cepteurs \u0153st : - ceux sur les ost\u00e9oblastes \n\t\t\t\t- mais pas ceux cell endom\u00e9triales et mammaires \n-> r\u00e9duit la perte osseuse post-MNP \t-  sans effets d\u00e9l\u00e9t\u00e8re sur l\u2019endom\u00e8tre \n\t\t\t- sans augmenter l\u2019incidence du cancer du sein et m\u00eame diminue ! \n\nMAIS : \t- ne suppriment pas les sympt\u00f4mes climat\u00e9riques \n\t- n\u2019ont pas la m\u00eame efficacit\u00e9 anti-fracturaire \n\t- ne r\u00e9duisent pas la fr\u00e9quence de la fracture du col f\u00e9moral \n\t\teffet pr\u00e9ventif sur les fractures vert 2x moindre"}}, {"contentCard": {"Q": "R/ curatif", "A": "ANTIRESORBEURS\t\n- Bisphosphonates \tPamidronate (IV) \n\t\tAlendronate (oral) \n\t\tRis\u00e9dronate (oral) \n\t\tZol\u00e9dronate  (IV) \n- Denosumab (anti-RANKL) (SC) \n\nOSTEOFORMATEUR \n- Peptides analogues PTH  \t[1-34] teriparatide (SC) FORSTEO \n\t\t[1-36] aboloparatide (SC) \n- Calcium-sensor receptor antagonists (SC)  -> augmentation de la PTH \n- Romosozumab (anti-scl\u00e9rostine) (SC) \n"}}, {"contentCard": {"Q": "R/ curatif Biphosphonates\n- m\u00e9canisme\n- 2 formes\n- point + ", "A": " = puissants inhibiteurs des ost\u00e9oclastes (favorise leur apoptose) , donc de la r\u00e9sorption osseuse. \n\nPO 1x/sem : \tBiodisponibilit\u00e9 - tr\u00e8s faible \n\t\t- pratiquement nulle en cas de prise alimentaire concomitante \n\t-> A JEUN  \t\n\t(alendronate, ris\u00e9dronate)\nIV 1x/an : \tElimination probl\u00e8me d'adh\u00e9sion  au traitement\n\t(zoledronate) \n\n+ : \t- Efficacit\u00e9 sur la DMO trab\u00e9culaire et corticale, avec gain de 5  \u00e0 10% en 3 ans,\n\t\t avec souvent un effet plateau. \n\t- Diminution du risque fracturaire d\u2019environ 50%  et rapidit\u00e9 ++ de cet effet. \n\t-> Effet magistral sur les fractures (encore + que sur DMO) \n\t-> sugg\u00e8re que l\u2019effet b\u00e9n\u00e9fique qualitatif, au-del\u00e0 d\u2019un gain quantitatif\n\n- : \teffet r\u00e9manent\n\n"}}, {"contentCard": {"Q": "R/ curatif biphosphonates\n- ES et pr\u00e9cautions", "A": "\n\n\nPO\t\n- \u0152sophage  \t\tUlc\u00e9rations \n\t\t-> ing\u00e9rer avec suffisamment d\u2019eau, \n\t\t-> \u00e9viter d\u00e9cubitus apr\u00e8s la prise \nIV  \n- R\u00e9action immunoall\tFi\u00e8vres, myalgies, arthralgies, syndrome inflammatoire \t\n\t\tNB : uniquement 1ere administration\n\n- Hypocalc\u00e9mie \tT\u00e9tanie calciprive \n\n- IRA  \t\t!! se m\u00e9fier si IR !!!  surtout s\u2019ils sont adminitr\u00e9s trop rapidement \n\t\t(oncologie) peuvent pr\u00e9cipiter une  IRA\n\t\t-> Administrer la m\u00e9dication en 60 minutes si r\u00e9duction de la FG\n\t\t-> S\u2019abstenir en cas d\u2019IR s\u00e9v\u00e8re  \nPO et IV : \n\n- Ost\u00e9on\u00e9crose mand. \tAbsence de cicatrisation apr\u00e8s avulsion dentaire \n\t\tSurinfection \n\t\tNB : risque excpetionnel mais nuit +++ r\u00e9putation\n\t\tPr\u00e9vention ++ : soins dentaires ad\u00e9quats avant mise en route du R/ \n\t\t\t+ extractions si n\u00e9cessaires avant R/ !!\n\n- Fracture diaphyse f\u00e9m. \tFracture low energy \n\t\tRare, Si administration prolong\u00e9e qui perturbe \u00e0 ce point le remodelage que l\u2019os \n\t\tdevient adynamique\n\t\t-> prescription sur 5 ans (max 10)"}}, {"contentCard": {"Q": "R/ curatif \n- prescription et suivi ", "A": "\nEN PRATIQUE : prescription\n- \u00e0 jeun avec grand verre d'eau debout pdt 30 min \n- attention si IR\n- soins dentaires\n- suppl\u00e9ments - de sels de calcium \n\t- et de vitamine D3 (charger les patients en D3 avant de d\u00e9marrer R/),\n- svt pendant une p\u00e9riode de 5 ans (maximum 10). \n\nUn effet r\u00e9manent est souvent observ\u00e9\n\nSUIVI : taux s\u00e9rique du CTX-I \nEvaluation rapide de l\u2019effet sur le remodelage apr\u00e8s 3 mois de R/ par la chute du taux s\u00e9rique du CTX-I. "}}, {"contentCard": {"Q": "R/ curatif Denosumab (prolia, xgeva) ", "A": "= anticorps monoclonal dirig\u00e9 contre RANK-L : bloque ++ r\u00e9sorption osseuse\n\nSC tous les 6 mois\n\n+ : \t- Gain de DMO - plus important qu\u2019avec les bisphosphonates, \n\t\t- se maintient plus longtemps. \n\t- Pas d\u2019effets r\u00e9manents : + par % aux bisphosp qui restent tr\u00e8s lgtps dans le tissu osseux. \n\t- IR n'est pas un CI sauf si os fortement sauf si os fortement adynamique\n\n- : \t- manque de recul , biphosphonate tjs 1\u00e8re intention\n\t- petit risque d'infection non d\u00e9montr\u00e9\n\t- prix \u00e9lev\u00e9 : Remboursement : - apr\u00e8s \u00e9chec biphosphonate ou ES\n\t\t\t- CI primaire aux biphosphonates (dim DFG)"}}]}, {"name": "Ost\u00e9omalacie + DD hypoCa++", "contentChapter": [{"id": 0, "contentCard": {"Q": "D\u00e9finition rachitisme et ost\u00e9omalacie", "A": "d\u00e9faut de min\u00e9ralisation de la matrice osseuse (tissu ost\u00e9o\u00efde) : \n - rachitisme = os en croissance \n- ost\u00e9omalacie  = os dont la croissance est termin\u00e9e. \n\nEtiologies identiques pour les 2 .\n\nNB : \n- OP : d\u00e9faut essentiellement quantitatif (moins de trame et moins de min\u00e9ral), \n- Rachitisme et ost\u00e9omalacie :  d\u00e9faut qualitatif : l'os est chimiquement anormal puisqu'il n'est pas - ou insuffisamment - min\u00e9ralis\u00e9\n\n L'os ost\u00e9omalacique \t- fragile \n\t\t- se fissure sans casser.\n\n Les ost\u00e9oblastes d\u00e9posent de l'ost\u00e9o\u00efde qui ne peut pas se calcifier \n-> exc\u00e8s de tissus ost\u00e9o\u00efde qui donne une consistance molle \u00e0 l'os"}}, {"contentCard": {"Q": "Etiologies", "A": "1. VITAMINIQUES : VITAMINE D\nInsuffisance d'apport : \tAlimentaire (source = poisson, viandre grasse) : v\u00e9g\u00e9talien\n\t\tAnh\u00e9lie (source = UV) = manque expo soleil\nD\u00e9faut d'absorption : \tSt\u00e9atorrh\u00e9e : insuff pancr\u00e9atique chronique \n\t\t\tcholestase chronique\n\t\t\tr\u00e9section intestinale \u00e9tendue\n\t\tMaladie de la muqueuse gr\u00eale : coeiliaquie\nTrouble m\u00e9tab interm :\tInsuff h\u00e9patique (25-hydroxylase) \n\t\tIR (1 alpha hydroxylase) \n\t\t-> dim masse n\u00e9phrotique  -> dim phosphaturie -> hyperphosphor\u00e9mie\n\t\t-> s\u00e9cr\u00e9tion FGF-23 par ost\u00e9ocytes \n\t\t-> phosphodiuritique + inhibtion 1-hydroxylase + stimule 24-hydrox\n\t\t-> dim calcitriol  -> dim abs intest Ca++ -> .. \n R\u00e9sistance p\u00e9riph\u00e9rique : \tVDDR maladie g\u00e9n\u00e9tique\n\t-> Dim absorption intest du Ca++ \n\t-> hypoCa++\n\t-> hyperparathyro\u00efdie secondaire\n\t-> augm r\u00e9sorption osseuse et r\u00e9abs tubulaire + phosphaturie \n\t-> augm phosphatase alcaline osseuse \n\t-> au total : dim Ca et P s\u00e9rique -> produit phosphocalcique < 25 \n\t-> min\u00e9ralisation tissus ost\u00e9o\u00efde compromise \n\n2. HYPOPHOSPHATEMIE CHRONIQUE\nRare : d\u00e9faut d'absorption et/ou d'apport - alcoolisme chronique\n\t\t\t- prise chronique de ch\u00e9lateurs (alumine, magn\u00e9sium)\nDiab\u00e8te phosphat\u00e9 : hyperphosphaturie par diminution r\u00e9absorption tubulaire du P\n\t- Maladie g\u00e9n\u00e9tique : rachitisme hypophosphat\u00e9mique ->  augm concentrat\u00b0 FGF-23\n\t- Tumeur m\u00e9senchymateuse (svt b\u00e9nigne) : production constitutive FGF23\n\t- Syndrome de Fanconi r\u00e9nale : diab\u00e8te + tubulopathie proximale globale\n\t\t- Causes h\u00e9r\u00e9ditaires : Dent, Cystinose, Lowe, Wilson, Galactos\u00e9mie\n\t\t- Toxiques : \tAntir\u00e9troviraux (VIH : tenofovir) \n\t\t\tCisplatine\n\t\t\tAminoside \n\t\t\tAc valpro\u00efques\n\t\t\tM\u00e9taux lourds : Pb , Hg, Cd\n\t\t- My\u00e9lomes multiple : paraprot\u00e9ines, chaines l\u00e9g\u00e8res\n\t\t- Amylose \n\t\t- Syndrome de Sj\u00f6gren \n\t-> PAS de : hypoC++ , carence vit D, hyperpathyr sec  \n\n3 . TOXIQUES : \taluminium chez les dialys\u00e9s\n4. MEDICAMENTS :  \tpremiers bisphosphonates disponibles, aujourd\u2019hui supp du march\u00e9 \n\nFormes 1 et 2 : absence de min\u00e9ral ( produit phosphocalcique < 25 ) \nForme 3 : toxique interf\u00e8re avec la min\u00e9ralisation. "}}, {"contentCard": {"Q": "Clinique", "A": "A l'inverse OP : D + \tchronique, diffuse\n\t\taxiale, rachidienne, scapulaire, thoracique et pelvienne\t\n\t\tsquelette diffus\u00e9ment sensible \u00e0 la palpation.\n\t\tfissures  \n\nMyopathie proximale : \t50 % des patients\n\t\tfaiblesse musculaire\n\t+++ s\u00e9v\u00e8re ds OM par hypophosphat\u00e9mie chronique (+ trac\u00e9 myog\u00e8ne \u00e0 l'EMG) \n\t\t! typique diab\u00e8te phosphat\u00e9\n\nSignes d'hypocalc\u00e9mie : \t+++ OM vitaminiques ! "}}, {"contentCard": {"Q": "Cliniques  : Signes de d'hypocalc\u00e9mie (OM vitaminiques) ", "A": "\nParesth\u00e9sies  (p\u00e9ribuccales et extr\u00e9mit\u00e9s ) \n\nSignes d'irritabilit\u00e9 neuro-musculaire : \n- Chvostek :  contraction des muscles p\u00e9ribuccaux en r\u00e9ponse \u00e0 une chiquenaude sur le nerf facial en avant de \n \tl'oreille (10 % des individus normocalc\u00e9miques ont un Chvostek positif a minima) \n- Trousseau : spasme carpien d\u00e9clench\u00e9 par l'anoxie (brassard tensionnel gonfl\u00e9 \u00e0 20 mm Hg au-del\u00e0 de la \n\tsystolique pendant 3 min) (exceptionnellement positif chez les individus normocal\u00e9miques)\n\nCrampes musculaires  : avec t\u00e9tanie et spasme carpo-p\u00e9dal = contracture MS et MI \n\nSi  s\u00e9v\u00e8re : ECG -> allongement espace QT \n\nSi chronique de l'hypoparathyro\u00efdie : Cerveaux  ->\tcalcificat\u00b0 des noyaux gris de la base\n\t\t\t\t\u00e9pilepsie \n\t\t                 Yeux ->\tCataracte sous-capsulaire"}}, {"contentCard": {"Q": "Diagnostic ", "A": "1. Biologie \n2. Radiologie conventionnelle \n3. Histologie sur biopsie "}}, {"contentCard": {"Q": "Diagnostic : Biologie", "A": "- D\u00e9couverte d'une hypocalc\u00e9mie et/ou d'une hypophosphor\u00e9mie - est toujours r\u00e9v\u00e9latrice.\n- Produit phosphocalcique diminu\u00e9\n- PTH \u00e9lev\u00e9e : hyperparathyro\u00efdie secondaire\n- Phosphatase alcaline osseuse augment\u00e9e\n- Vit D (celle dos\u00e9e en clinique = 25-OH-vit D3)  : effondr\u00e9e\n\n! Calc\u00e9mie totale (nl : 8,8 \u00e0 10,4 mg/dl ou 2,2 \u00e0 2,6 mmoles/L) est fct de PROTIDEMIE  (surtout albumin\u00e9mie) \n- 1/2 Ca li\u00e9 au prot\u00e9ines\n- \u00f4 1/2 (libre, ionis\u00e9, Ca++) physiologiquement active\nCalc\u00e9mie totale corrig\u00e9e pr la protid\u00e9mie peut \u00eatre calcul\u00e9e apd calc\u00e9mie totale mesur\u00e9e \n\n(! Taux de calium ionis\u00e9 est fct du pH )\n- Acidose augm Ca ionis\u00e9 en dim liaison des ions Ca++  \u00e0 l'albumine \n- Alcalose r\u00e9duit Ca ionis\u00e9 en augm fixation des ions Ca++ \u00e0 l'albumine\n\t-> Spamophile : \thyperventilation \"neurog\u00e8ne\", \n\t\t\tdyspn\u00e9e soupirante, \n\t\t\talcalose respiratoire, \n\t\t\tcalc\u00e9mie totale normale, \n\t\t\tcalcium ionis\u00e9 abaiss\u00e9 \n\t\t\tsignes cliniques d'hypocalc\u00e9mie"}}, {"contentCard": {"Q": "DD des hypocalc\u00e9mie de l'adulte\n+ en pratique r\u00e9flexes a avoir", "A": "\"Fausses hypoCa++ = pseudo-hypoCa++  \" secondaires \u00e0 une hypoalbumin\u00e9mie \n\t\t- maladies chroniques, d\u00e9nutrition \n\t\t- syndrome n\u00e9phrotique, prot\u00e9inurie \n\t\t- cirrhose , insuffisance h\u00e9patique\n\t\t-> Ca total bas MAIS Ca libre (Ca++), ou calcium ionis\u00e9 nl\n\nHypocalc\u00e9mies aigu\u00ebs \tIRA  :  dim phosphaturie -> hyperphosphat\u00e9mie -> ch\u00e9lation du Ca\n\t\tBisphosphonates IV  : inh ost\u00e9oclaste -> blocage r\u00e9sorption osseuse \n\t\t\t(ES rare mais transitoire, surtt si grosse dose , onco)\n\nHypocal\u00e9mies chroniques \tCarence vit D3 +++ surtt si IRC (via FGF-23) \n\t\tHypoparathyro\u00efde \n\nEN PRATIQUE : Ca total bas \n1. Doser Ca libre + \u00e9lectrophor\u00e8se des prot\u00e9ines \n2. Tester la fct r\u00e9nale "}}, {"contentCard": {"Q": "Diagnostic Rx ", "A": "peut aider au diagnostic dans  cas s\u00e9v\u00e8res et chroniques \n- os de structure floue et d\u00e9lav\u00e9e\n- vert\u00e8bres biconcaves \n- stries de Looser  = pseudo-fractures : l'os se fissure sans casser\n   situ\u00e9es perpendiculairement aux corticales qui correspondent \n\t- radiologiquement \u00e0 une zone de d\u00e9calcification en bande \n\t- histologiquement, \u00e0 du tissu ost\u00e9o\u00efde non min\u00e9ralis\u00e9\n\n   Localisat\u00b0   - bassin (ailes iliaques, branches ischiopubiennes et iliopubiennes), \n\t- f\u00e9mur (bord interne du col f\u00e9moral), \n\t- m\u00e9tatarsiens \n\t- c\u00f4tes"}}, {"contentCard": {"Q": "Diagnostic : histologie", "A": "= preuve formelle de l'OM  mais elle est rarement indispensable, tant les anomalies biologiques sont suggestives. \n\n-  histologie osseuse  confirmera l'exc\u00e8s de tissus ost\u00e9o\u00efde\n- Allongement du d\u00e9lai de min\u00e9ralisation : appr\u00e9ciable par double marquage \u00e0 la t\u00e9tracycline\n "}}, {"contentCard": {"Q": "R/ en fonction de son \u00e9tiologie", "A": "FORMES VITAMINIQUES : \n- Vitaminoth\u00e9rapie \n- Associ\u00e9e \u00e0 calcith\u00e9rapie \n-> correction ad integrum des l\u00e9sions radiologiques et du tableau clinique si ad\u00e9quates \n\nVitamine D3 \"simple\"  \n- la plupart du temps suffisante, \n- surtt ds formes vitaminiques par insuffisance d'apport non compens\u00e9e par expo solaire. \n\nCas particuliers  (IRC) : m\u00e9tabolites hydroxyl\u00e9s \n- se me\u0301fier d'un R/ intempestif (trop prolong\u00e9ou avec des m\u00e9tabolites trop actifs qui ne sont pas soumis aux m\u00e9canismes physiologiques de r\u00e9trocontr\u00f4le) qui peut provoquer une hypercalc\u00e9mie. \n\nFORMES HYPOPHOSPHATEMIQUES : \ncalcitriol (0,5 a\u0300 2 \u03bcg/j) \net - si n\u00e9cessaire - phosphore (1-4 g/jour, id\u00e9alement en 4-5 prises). \n\nCalcitriol  : effets\n- absorption intestinale du phosphore\n- contrecarrer l'hyperparathyro\u00efdie secondaire \u00e0 l'hypoca induite par le R/ phosphor\u00e9 (effet ch\u00e9lateur exerc\u00e9 par le phosphore sur le calcium au niveau de la lumi\u00e8re intestinale)  par son effet inhibiteur direct sur la synth\u00e8se de la PTH. \n\nFORMES HYPOPHOSPHATEMIQUES SECONDAIRE A UNE TUMEUR MESENCHYMATEUSE\n-> ++ Bonne r\u00e9ponse \u00e0 l'ex\u00e9r\u00e8se de la tumeur si elle est compl\u00e8te\n et/ou a\u0300 l'administration de phosphore et de calcitriol. "}}]}, {"name": "Maladie de Paget", "contentChapter": [{"id": 0, "contentCard": {"Q": "D\u00e9finition \nLocalisations", "A": "D\u00e9sordre localis\u00e9 du remodelage \n- initi\u00e9 par une augmentation de la r\u00e9sorption ost\u00e9oclastique \n- avec en cons\u00e9quence une augmentation compensatoire de la formation osseuse. \n\nAu total, l'os pag\u00e9tique\n- est \"anarchique\"\n- a perdu sa structure lamellaire, \n- est plus large, \n- moins compact, \n- plus vascularis\u00e9 \n- et plus susceptible de casser\n\nN'est pas une maladie osseuse diffuse, mais focale, UNI- ou PLURIFOCALE\n\nLes sites les + fr\u00e9quemment atteints \t+++ : bassin,  f\u00e9mur,  vert\u00e8bres lombaires\n\t\t\t+ : cr\u00e2ne  , tibia , hum\u00e9rus \n\t\t\t mais peut atteindre n'importe quel os. "}}, {"contentCard": {"Q": "Etiologie", "A": "PEU CONNUE\n\nCOMPOSANTE GENETIQUE PROBABLE : \n- Maladie in\u00e9galement r\u00e9pandue dans le monde, \n\t- nettement plus fr\u00e9quente en Europe, en Am\u00e9rique du Nord et en Australie, \n\t- plus rare en Asie et en Afrique. \n- 15% des patients ont une histoire familiale de maladie de Paget. \n\tDans cette cat\u00e9gorie d\u2019individus, on trouve des mutations communes (g\u00e8ne codant pour une \t\n\tprot\u00e9ine r\u00e9gulatrice des ost\u00e9ocalstes)  \n\nORIGINE VIRALE ? La d\u00e9couverte d'inclusions ressemblant \u00e0 des nucl\u00e9Ocapsides virales dans les noyaux et le cytoplasme des ost\u00e9oclastes des sites pag\u00e9tiques, ont fait \u00e9voquer une origine virale (paramyxovirus) mais il se pourrait que ces structures correspondent en fait \u00e0 des aggr\u00e9gats prot\u00e9iques r\u00e9sultant d\u2019un processus autophagique inad\u00e9quat. "}}, {"id": 1, "contentCard": {"Q": "Clinique\nEvolution\nComplication ", "A": "D\u00e9couverte\n- patients > 50 ans, mais \u00e9volue probablement d\u00e9j\u00e0 depuis de nombreuses ann\u00e9es avant le diag\n- ++ ASYMPTOMATIQUE : le +  souvent fortuitement suite \u00e0 un examen \n\t-  bio (\u00e9l\u00e9vation du taux s\u00e9rique de la phosphatase alcaline osseuse totale) \n\t- radio (ex : abdomen \u00e0 blanc demand\u00e9 suite \u00e0 une douleur abdominale aigue).\n- D+  OSSEUSE : - peut \u00eatre r\u00e9v\u00e9latrice \n\t- y compris nocturne \n\t- due \u00e0 l'hyperh\u00e9mie \n\t-> R/\n\nManque de rigidit\u00e9 de l'os : \n-> incurvat\u00b0 des os longs qui plient sous les contraintes (tibias en lame de sabre, osteitis deformans). \n-> D\u00e9fauts d'alignement \n-> Arthrose secondaire des ar sus- et sous-jacentes. \n-> R/ si atteinte des os long sujet jeune\n\nAtteinte des \u00e9piphyses \n-> arthrose par atteinte directe de l'os sous-chondral (coxopathie pag\u00e9tique). \n\nAtteinte du cr\u00e2ne -> tjs R/\n-  augmentat\u00b0 progressive p\u00e9rim\u00e8tre \n\t-> signe du chapeau \n-  platybasie (aplatissement de la base du cr\u00e2ne) \n\t->  impression basilaire = ascens\u00b0 de l'apophyse odonto\u00efde de l'axis dans trou occipital \n\t->  potentielle - compression du tronc c\u00e9r\u00e9bral\n\t\t- ou hydroc\u00e9phalie \n- compression nerf cr\u00e2nien \n\t-  atteinte du rocher (VIII) -> surdit\u00e9 neurosensorielle\n\t-  II, VI et VII\n\n- h\u00e9mod\u00e9tournement carotidien externe aux d\u00e9pens du r\u00e9seau carotidien interne (Paget voleur) \n\t-> Sd neurologique :  somnolence , apathie\n\nAtteinte de la colonne \n- compression radiculaire ou m\u00e9dullaire   -> R/\n- vol vasculaire aux d\u00e9pens de l'art\u00e8re spinale. \n\nFractures d'un os pag\u00e9tique (+++ diaphyse et col f\u00e9moral ) : l'os d\u00e9form\u00e9 est fragilis\u00e9 \n->  h\u00e9morragies s\u00e9v\u00e8res \u00e0 cause de l'hypervascularisation. \n\nFissures\tt\u00e8s fr\u00e9quentes \n\tsouvent spontan\u00e9es \n\tg\u00e9n\u00e9ralement indolores. \n\tsurviennent particuli\u00e8rement au niveau de la convexit\u00e9 des os des MI \n\nTransformation n\u00e9oplasique :  sarcomes ost\u00e9og\u00e9niques (plus rarement les chondro- et fibrosarcomes)\n\ttr\u00e8s rare (< 1% des cas ),  paget = lit du sarcome\n\tmais redoutable car presque toujours fatale. \n\tlocalisation : bassin,  f\u00e9mur, hum\u00e9rus \n\t!!! y songer : majoration brutale - des douleurs \n\t\t\t- du taux s\u00e9rique de la phosphatase alcaline\n\t\t\t en l'absence d'explication fracturaire"}}, {"contentCard": {"Q": "Diagnostic", "A": "1. Rx  : souvent suffisant pour le diag\n2. Scintigraphie osseuse : indispensable au bilan initial\n3. Biologie : \u00e9l\u00e9vation phosphatase alcaline osseuse r\u00e9velle souvent l'affection , mais non sp\u00e9cifique"}}, {"contentCard": {"Q": "Diagnostic Rx", "A": "\nassociation signant l'affection : \n-  \u00e9largissement de la pi\u00e8ce osseuse\n- densification de la trame faite de trav\u00e9es osseuses \u00e9paissies et de direction anarchique = tr\u00e8s blanc\n- DEDIFFERENCIATION CORTICOMEDULLAIRE\n- l\u00e9sions lytiques : ost\u00e9olyse = noir\n\nOs longs : \n- front de progression lytique (front rar\u00e9fiant) en fer de lance,\n- suivi dans le temps et dans l'espace d'une reconstruction qui balaie l'os lentement, mais surement, \u00e0 la vitesse moyenne de 0,8 cm par an et qui, s'il ne franchit effectivement JAMAIS le cartilage, peut exceptionnellement passer d'un os \u00e0 l'autre via un ost\u00e9ophyte. \n\nCr\u00e2ne : \n- ost\u00e9olyse (dite circonscrite) suivie de ph\u00e9nom\u00e8nes de reconstruction ost\u00e9oblastique dispos\u00e9s en il\u00f4ts. \n- Absence de contraintes m\u00e9caniques au niveau du cr\u00e2ne \n\t->  lenteur relative des ph\u00e9nom\u00e8nes de reconstruction. \nVert\u00e8bres : \n- possible st\u00e9nose du canal rachidien. \n\nreconna\u00eet par ailleurs \n-  d\u00e9formations, \n-  fissures, \n- fractures, \n- arthroses secondaires, \n- transformation n\u00e9oplasique \n\nSUIVI : place essentielle dans l'appr\u00e9ciation de l'efficacit\u00e9 d' un R/ "}}, {"contentCard": {"Q": "Diagnostic scintigraphie osseuse", "A": "\nindispensable au moment du bilan initial ->identifier l'ensemble des foyers pag\u00e9tiques m\u00eames \n- ceux  (encore) radiologiquement muets\n- ceux techniquement difficiles \u00e0 radiographier ( omoplates, sternum,  clavicules et c\u00f4tes) \n\nNON DIAG : indique juste la localisation\nPAS DANS LE SUIVI : ne pas r\u00e9p\u00e9ter -> peu d'info , pas d'appr\u00e9ciation des r\u00e9sultats d'un R/\n\ntypique d'un paget : scinti tr\u00e8s +++\n"}}, {"contentCard": {"Q": "Diagnostic Biologie ", "A": "Marqueurs du remodelage osseux : \n- Phosphatase alcaline osseuse (formation) : \u00e9lev\u00e9e \tSUFFISANTE\n- PINP (formation) : \u00e9lev\u00e9 \t\t\tNE PAS DEMANDER EN ROUTINE \n- CTX-I (r\u00e9sorption) : \u00e9lev\u00e9 \t\t\tNE PAS DEMANDER EN ROUTINE \n\nReste de pds : normale\n- Calc\u00e9mie tjs normale sauf en cas \n\t- d'immobilisation : \n\t  perte du stimulus positif de la mise en charge sur l'activit\u00e9 des ost\u00e9oblastes \n\t  -> d\u00e9couple la formation de la r\u00e9sorption\n\t  -> hyperCa++  et hypercalciurie transitoires\n\t- d'hyperparathyro\u00efdie primitive (5 % des patients pag\u00e9tiques). \n\nNB  : El\u00e9vation phosphatase alcaline osseuse : \n- r\u00e9v\u00e8le souvent l'affection, pass\u00e9e jusque-l\u00e0 inaper\u00e7ue -> indication de faire une scintigraphie osseuse\n- NON sp\u00e9cifique\n- permettent d'appr\u00e9cier\t-  l'extension de la maladie,\n \t\t- son degr\u00e9 d'activit\u00e9e\n\t\t- la r\u00e9ponse au R/  = SUIVI\n->  les marqueurs du remodelage osseux seront d'autant plus pathologiques que la maladie est active et/ou \u00e9tendue. "}}, {"contentCard": {"Q": "R/ indications ", "A": "Symptomatique : tjs\n- Douleurs osseuses = indication FORMELLE\n- Compression - radiculaire \n\t- et/ou m\u00e9dullaire \n\nAsymptomatique +++ : au cas par cas  \nAtteinte \t- du bassin mena\u00e7ant le cotyle  (PAS si patient ag\u00e9, loin du cotyle) \n\t- du cr\u00e2ne\n\t- du MI asymptomatiques chez sujets JEUNE (f\u00e9mur, OS LONG en g\u00e9n\u00e9ral) \n\t\t-> risque modification condyle, arthrose\n\n(- Pr\u00e9-chirurgie osseuse (pr\"venir l\u2019h\"morragie et renforcer l\u2019os) ) \n(- Immobilisaiotn suite \u00e0 une fracture (pr\u00e9venir l\u2019hypercalc\u00e9mie) ) \n\nNB : traiter plus pr\u00e9coc\u00e9ment les formes qui atteignent les  MI, particuli\u00e9rement chez les sujets jeunes m\u00eame asymptomatiques \u2013 depuis que nous disposons des bisphosphonates. \n\n"}}, {"contentCard": {"Q": "R/ ", "A": "BUT : \t- antalgie, \n\t- am\u00e9liorer la qualit\u00e9 de l'os pour \n\t\t- r\u00e9duire le risque de fracture spontan\u00e9e, \n\t\t- freiner l'incurvation des os \n\t\t- pr\u00e9venir les d\u00e9formations du cr\u00e2ne et des os de la face, \n\t\t\tl'impression basilaire, \n\t\t\tla paralysie des nerfs cr\u00e2niens\n\t\t\tla baisse de l'audition. \nBIPHOSPHONATES :   pamidronate, ris\u00e9dronate, alendronate , acide zole\u0301dronique,\n\t-  R/ de choix \n+  : \t- tr\u00e8s efficaces pr inhiber ost\u00e9oclastes \n\t-  effets souvent prolong\u00e9s.\n\t- normalisent tr\u00e8s rapidement - l\u2019acc\u00e9l\u00e9ration du remodelage\n\t\t- +++ les indices de r\u00e9sorption (CTX-1)  : chutent avt phosphatase alcaline\n\n- , ES : \tpfs Hypocalc\u00e9mie transitoire rarement symptomatique d\u00fbe au d\u00e9couplage r\u00e9sorption-formation"}}, {"contentCard": {"Q": "R/ suivi ", "A": "CHUTE/ NORMALISATION DES MARQUEURS \n- Phosphatase alcaline (formation)\n- PINP (formation)   : plus cher mais chute plus rapide\n\nPAS DE SCINTIGRAPHIE \n\nSUIVI RADIOLOGIQUE !!  de l'effet th\u00e9rapeutique\n-  particuli\u00e8rement rigoureux et donc d\u00e9licat \n-  au niveau des os porteurs de l\u00e9sions lytiques, susceptibles d'\u00eatre reconstruites. \n- permet de confirmer que le bilan osseux focal est positif bien plus qu'une normalisation du taux de la phosphatase alcaline"}}]}, {"name": "Les hypercalc\u00e9mies", "contentChapter": [{"id": 0, "contentCard": {"Q": "DD Fausse hypercalc\u00e9mie et \u00e9tiologie", "A": "\nEl\u00e9vation de la calc\u00e9mie totale sans mofif du calcium ionis\u00e9 \nsuite \u00e0 toute \u00e9l\u00e9vation de l'albumin\u00e9mie  : \t- D\u00e9hydratation \n\t\t\t- H\u00e9moconcentration (stase veineuse < pose prolong\u00e9e d'un garrot"}}, {"id": 1, "contentCard": {"Q": "Etiologie", "A": "NE JMS BANALISER une v\u00e9ritable hypercalc\u00e9mie \n\nRETENIR : hyperpara, cancer, sarco\u00efdose, intox vit D (rare) \n\nEtiologies fr\u00e9quentes\t- Hyperparthyro\u00efdie primitive (via PTH) \n= exc\u00e8s r\u00e9sorpt\u00b0\t- Cancer : \tSd paran\u00e9oplasique : HyperCa humorale maligne (s\u00e9cr\u00e9t\u00b0 de PTH-RP)\n= 80% des hyperCa\t\t\t-> Leuc\u00e9mie, cancer \u00e9pidermo\u00efde,..\t \n\t\t\tM\u00e9tastases osseuses ost\u00e9olytiques \n\t\t\t\t-> Cancer du sein\n\t\t\tS\u00e9cr\u00e9tion de cytokine avec actitivit\u00e9 stimulant ost\u00e9oclastes\n\t\t\t\t-> My\u00e9lome multiple \n\t\t\tProduction ectopique de calcitriol \n\t\t\t\t-> Lymphomes\n\nEtiologies moins fr\u00e9q \t- Sarco\u00efdose (production de calcitriol)  = exc\u00e8s abs intest de Ca++\n\t\t- Hyperthyro\u00efdie (d\u00e9couplage formation-r\u00e9sorption au profit de la r\u00e9sorption) \t\t\t- M\u00e9dicaments  : Vitamine D et analogues (intox)  = exc\u00e8s abs intest Ca++\n\t\t\tThiazides (augm de la r\u00e9abs tubulaire distale du calcium) \n\t\t\tLithium (dim de la sensibilit\u00e9 des parathyro\u00efdes \u00e0 l'hypercalc\u00e9mie) \n\t\t\tVitamine A (intoxication) \n\t\t- IR  (hyperparathyro\u00efdie tertiaire) \n\t\t- Immobilisation (si remodelage acc\u00e9l\u00e9r\u00e9)\n\nEtiologies rares \t- Hypercalc\u00e9mie hypocalciurique familiale \n\t\t- Granulomatoses infectieuses (tuberculose, histoplamose, coccidio\u00efdomycose) \n\t\t- Milk alkali syndrome \n\t\t- Ph\u00e9ochromocytome \n\t\t- Maladie d\u2019Addison "}}, {"id": 2, "contentCard": {"Q": "Clinique\n+ pratique", "A": "VARIABLE : \n- de d\u00e9couverte fortuire \u00e0 urgence m\u00e9dicale ! \n\t-  rarement symptomatique <  12 mg/dl   (++ Hypeerparathyr primitive et cancer) \n\t-  virtuellement toujours symptomatique > 14 mg/dl. \n\n- signes gastro-intestinaux  ++++: \tconstipation, \n\t\t\tanorexie, \n\t\t\tN+ \n\t\t\tV+ \n- polyurie- polydipsie : \t\thyperCa++ (s\u00e9v\u00e8re) interf\u00e8re action ADH (PTH= anti-ADH) \n\t\t\t-> impossibilit\u00e9 concentrer urines\n\t\t\t-> Diab\u00e8te inscipide n\u00e9phrog\u00e9nique  (ADH ok mais pas active)\n\t\t\t= IR fonctionnelle\n- sympt neurologiques fr\u00e9q : \tdifficult\u00e9s de concentration, \n   = troubles cognitifs\t\tapathie, \n\t\t\td\u00e9pression, \n\t\t\tconfusion,\n\t\t\tfaiblesse musculaire, \n\t\t\tcoma. \n- D\u00e9shydratation (typique hyperCa+) \t< polyurie + v+ \n- Lithiases r\u00e9nales fr\u00e9q : \t\t15 % des patients avec hyperparathyro\u00efdie primitive (car chronique)\n-  N\u00e9phrocalcinose + rare\n\nCARDIO  :  \tECG : raccourcit l'espace QT \n\tsensibilise les patients aux effets des digitaliques. \n\nEN PRATIQUE : 80% hypercalc\u00e9mie = HPP et cancers\nHPP : \n- DD clinique facile\n- ++  hyperca  < 12 mg/dl ,  calc\u00e9mies pathologiques depuis plusieurs mois ou plusieurs ann\u00e9es.\n- fr\u00e9quemment asymptomatiques \n- si  sympt : ++ complications chroniques \n\nNeoplasie : \n-  souvent symptomatiques, \n- souvent d'ailleurs de mani\u00e8re plus aigue\n"}}, {"contentCard": {"Q": "Diagnostic ", "A": "Rein =  r\u00f4le capital car premier d\u00e9fenseur face \u00e0 l'hypercalc\u00e9mie via une HYPERCALCIURIE\nHYPERCALCEMIE seulement quand la capacit\u00e9 calciurique du rein est d\u00e9passe\u0301e. \n-> hypercalc\u00e9mie accompagn\u00e9e et svt pr\u00e9c\u00e9d\u00e9e par une hypercalciurie  \n-> LITHIASE\n\n\nDosage de PTH intacte :  DD des cas difficiles : \n- TJS BASSE pour la calc\u00e9mie (car down-r\u00e9gul\u00e9e par hyperCa++) ->  hypercalc\u00e9mies n\u00e9oplasiques (sauf les exceptionnels cancers parathyro\u00efdiens)\n- TJS NORMALE ou HAUTE  pour la calc\u00e9mie dans l'HPP (normalement elle devrait \u00eatre indosable en cas d'hyperCa !) \n\n"}}, {"contentCard": {"Q": "R/ ", "A": "Indication : chez tous les patients symptomatiques, y compris dans les hypercalc\u00e9mies n\u00e9oplasiques. \n\n- REHYDRATER : \n\t- solut\u00b0 physio de NaCl -> corriger d\u00e9ficit li\u00e9 aux V+ et aux d\u00e9fauts de concentrat\u00b0 des urines\n\t- Furos\u00e9mide :  augmente la calciurie ->  compl\u00e9ment utile \u00e0  la r\u00e9hydratation. \n\t- CI  diur\u00e9tiques de l'anse en l'absence d'une r\u00e9hydratation ade\u0301quate. \n\n- BIPHOSPHONATES en IV (pamidronate ou zol\u00e9dronate) \n\t- car cause hyperca = ++ augm r\u00e9sorption \n\t- MAIS abaissement de la calc\u00e9mie transitoire en l'absence de R/ \u00e9tiologique. \n\n(- si hyperca extr\u00eames :  dialyse dialysat pauvre en calcium )\n\n- GLUCORTICO\u00cfDES : tr\u00e8s utile pour hyperCa associ\u00e9es \u00e0  : \n\t(- Effet cytostatique -> h\u00e9mopathies malignes et my\u00e9lome ) \n\t- Dim abs intest Ca ->   exc\u00e8s de calcitriol (intoxication \u00e0 la vitamine D, sarco\u00efdose) \n\t- Inh 1\u03b1-hydroxylase extrar\u00e9nale -> Sarco\u00efdose \n\n- R/ETIOLOGIQUE indispensable \n\t-  chimioT dans les hyperca malignes \n\t-  parathyro\u00efdectomie dans l'HPP. "}}]}, {"name": "HPP = hyperparathur primitive = 1 cause princ d'hyperCa", "contentChapter": [{"id": 0, "contentCard": {"Q": "Epid\u00e9miologie ", "A": "- Augm de l'incidence de la maladie due essentiellement \u00e0 la d\u00e9termination plus fr\u00e9quente de la calc\u00e9mie souvent demand\u00e9 dans le cadre d'un bilan g\u00e9n\u00e9ral pour des plaintes asp\u00e9cifiques. \n\n-  survient \u00e0 tout \u00e2ge, , mais plus fr\u00e9quente > 60 ans \n\n-  un peu plus fr\u00e9q chez la femme (3F/2H)"}}, {"id": 1, "contentCard": {"Q": "Etiologie", "A": "- ADENOME  PARATHYRO\u00cfDIEN 80% \n- HYPERPLASIE GLANDULAIRE DIFFUSE des 4 parathyr  20% \n- (rares carcinomes parathyr  (< 1% des HPP)) \n-> perte r\u00e9trocontr\u00f4le CaSR\n\nLes formes familiales s'int\u00e8grent dans le cadre nosologique des polyendocrinopathies (MEN, Multiple Endocrine Neoplasias) discute\u0301es en endocrinologie. \n\n"}}, {"id": 2, "contentCard": {"Q": "Clinique\nComplication", "A": "RARE :  \"crise hypercalc\u00e9mique\" ou \"crise hyperparathyro\u00efdienne\", \n-> signes cliniques devenus tr\u00e8s rare car diagnostic plus pr\u00e9coce, sauf n\u00e9phrolithiase = complication fr\u00e9quente\n\nComplications \n- N\u00e9phrolithiase\n- Osseuses fort rares, sauf l'OP "}}, {"id": 3, "contentCard": {"Q": "Diagnostic, Bilan", "A": "1. Masse osseuse (surtout corticale) diminue chez les hyperparathyr au prorata de l'hypercalc\u00e9mie (et certainement si la calc\u00e9mie de\u0301passe 11,5 mg/dl). \n-> TJS  \t- Rx :  rechercher r\u00e9sorption sous p\u00e9riost\u00e9e au niveau des corticales des secondes phalanges \n\t- Ost\u00e9odensitom\u00e9trie \n\n2. BIOLOGIE :\n \u00e9vocatrice mais non sp\u00e9cifique : \n- HyperCa++ vraie avec hypophosphat\u00e9mie\n- acidose hyperchlor\u00e9mique :\tPTH inhibe r\u00e9abs tubulaire proximale des bicarbonates\n\t\t-> acidose et hyperchlor\u00e9mie. \n- Marqueurs de remodelage (phosphatase, r\u00e9sorption) \u00e9lev\u00e9s ds formes avec importantes r\u00e9percussions os\n\nsp\u00e9cifique ++  : taux circulant de PTH\n->  si hyperca , taux \u00e9lev\u00e9 (et m\u00eame \"normal\") de PTH affirme virtuellement le diagnostic : toute autre cause d'hypercalc\u00e9mie rendrait la PTH indosable. \n\n(\u00f4 : )\n- augm calcitritol  (car la PTH stimule la 1\u03b1-hydroxylase), \n- excr\u00e9tion accrue d'AMPc urinaire (second messager de la PTH) \n- hypercalciurie, a priori paradoxale puisque la PTH augmente la r\u00e9sorption tubulaire distale du calcium\n\t-> expliqu\u00e9 par augm charge calcique filtr\u00e9e + inhibition r\u00e9absorption par hyperCa++\n\n\n4. Nombreux examens compl\u00e9mentaires  :  ,ECHO,  CT-scan , IRM , scintigraphie au MIBI, ...  \n\n5. mais l\u2019essentiel est de confier nos malades \u00e0 un CHIRURGIEN EXPERIMENTE : \n-  Dans ces conditions, l'EXPLORATION CHIRURGICALE est couronn\u00e9e de succ\u00e8s dans 95 % des cas. \n- Si \u00e9chec chirurgical (tjs hyperCa) : envisager parathyro\u00efde ectopique (par ex. dans le m\u00e9diastin). "}}, {"id": 4, "contentCard": {"Q": "R/ \nindications\n(Complications)", "A": "CHIRURGICAL \n-   patients symptomatiques TJS \n\t- n\u00e9phrolithiases r\u00e9cidivantes, \n\t- l\u00e9sions osseuses : ex OP secondaire\n\t- sympt\u00f4mes d'hypercalc\u00e9mie\n-  patients asymptomatiques SSI \n\t- Calc\u00e9mie mesur\u00e9e de mani\u00e9re r\u00e9p\u00e9t\u00e9e \u00e0 plus de 1 mg/dl au-del\u00e0 de la valeur normale \n\t\tHypercalciurie, .. \n\t- eGFR <60 ml/min/1,72 m2 de surface corporelle \n\t - MO basse: T-score \u22642.5  \u00e0 n\u2019importe o\u00f9\n\t- Atcds de fracture de fragilit\u00e9\n\t- Age <50 ans   (85 ans , asympto -> pas R/) \n\t-> D\u00e9couverte d'une ost\u00e9op\u00e9nie chez jeune ++++ R/\n\n(Complications de la chirurgie  : )\n- hypoparthyro\u00efdie d\u00e9finitive : rare \n- hypocalc\u00e9mie transitoire fr\u00e9quente :  dispara\u00eet rapidement lorsque les parathyro\u00efdes laiss\u00e9es en place, jusque- l\u00e0 sid\u00e9r\u00e9es par l'hypercalc\u00e9mie, retrouvent leur sensibilit\u00e9 \u00e0 la calc\u00e9mie. \n- Hungry brone syndrome : patients souffrant de complications osseuses \u00e9tendues -> hypocalc\u00e9mie peut \u00ea plus prolong\u00e9e\n\nPas de bon R/non chirurgical de l'HPP.\n- hydratation correcte, \n- \u00e9viter les thiazides \n- limiter les apports calciques (++ patients taux de calcitriol est \u00e9lev\u00e9). \n\n(Les quelques rares patients symptomatiques inop\u00e9rables recevront un bisphosphonate. )"}}, {"contentCard": {"Q": "SUIVI apr\u00e8s R/", "A": "- v\u00e9rifier la calc\u00e9mie et les chiffres tensionnels tous les 6 mois. \n- mesurer clearance de la cr\u00e9atinine et la masse osseuse, particuli\u00e8rement corticale annuellement"}}]}, {"name": "Algodystrophie sympathique r\u00e9flexe = Sd douloureux r\u00e9gional complexe", "contentChapter": [{"id": 0, "contentCard": {"Q": "D\u00e9fintion \nLocalisation", "A": "= ADSR\n- pas qu'une pathologie osseuse stricto sensu\n- drame vasomoteur qui perturbe la trophicit\u00e9 de tous les tissus d'un membre ou d'une r\u00e9gion d'un membre. \n\nMI +++ : \t- cheville et pied  ++\n\t- hanche : pas rare , diag + difficile DD ost\u00e9on\u00e9crose aseptique -> IRM pour DD\n\nMS : \t- main, poignet +++\n\t- pfs associ\u00e9 \u00e9paule"}}, {"contentCard": {"Q": "Physiopathologie", "A": "Imparfaitement \u00e9lucid\u00e9e : perturbation fonctionnelle du syst\u00e8me nerveux sympathique\n->  alt\u00e9ration de la microcirculation \n-> stase vasculaire dans laquelle le tissu osseux \"fond\". "}}, {"id": 1, "contentCard": {"Q": "Etiologie", "A": "++++ suite \u00e0 TRAUMA \t- fractures,\n\t\t- fissures d\u2019insuffisance de r\u00e9sistance osseuse,\n\t\t- entorses\n\t\t- chirugie orthop\u00e9dique, etc.\n\nGROSSESSE \t\t= cause non exceptionnelle d\u2019ADSR de la hanche : facteurs m\u00e9caniques, surtout T3  !! \n\t\t-> stress m\u00e9canique hanche -> fissures t\u00eate f\u00e9morale \n\nPfs  maladies internistiques (infarctus du myocarde) \n\tou neurologiques (accident vasculaire c\u00e9r\u00e9bral)  \n\n1/3 des cas : pas d'\u00e9tio trouv\u00e9e\n\nTerrain de labilit\u00e9 psychologique et \u00e9motionnelle ++"}}, {"id": 2, "contentCard": {"Q": "Clinique", "A": "Syndrome clinique polymorphe comportant \n\t- des douleurs, \n\t- un aspect pseudo- inflammatoire, \n\t- des perturbations vasomotrices, \n\t- une stase vasculaire \n\t- un remodelage osseux acc\u00e9l\u00e9r\u00e9 ->  on en parle donc ds le chapitre des pathologies osseuses\n\n Variabilit\u00e9 +++ : expression clinique et \u00e9volution varient consid\u00e9rablement \n- d'un patient \u00e0 l'autre : \tStades pas tjs individualis\u00e9s, certains d'embl\u00e9e stade dystrophique\n\n- d'un site \u00e0 l'autre : \thanche -> g\u00e9n\u00e9ralement pas des troubles vasomoteurs \n\t\tPied , main -> troubles vasomoteurs ++\n\n3 STADES\n1. inflammatoire ou chaud : \t\u0153d\u00e8me \n\t\tD+ art et p\u00e9ri-art de rythme inflamm (ou m\u00e9canique ds MI  o\u00f9 D+ ++ \u00e0 la mise en charge)  \n\t\tAlgie locor\u00e9gionale, \u00e0 l'inverse de la d+ d'une arthrite qui est bcp plus locale\n\t\tt\u00e9guments  cyanotiques. \n\n2. dystrophique ou froid : \tperturbations vasomotrices : membre atteint \n\t\t\t-  froid, \n\t\t\t- hyperhydrotique \n\t\t\t- souvent glabre.\n\n3. s\u00e9quellaire : \tl\u00e9sions atrophiques de la peau (aspect scl\u00e9rodactylique)\n\t\tfibrose des\t-  capsules articulaires, \n\t\t\t- fascias, \n\t\t\t- muscles \n\t\t\t- tendons (\u00e9ppaule gel\u00e9e, main en griffe). \n\t\tCe tableau est loin d'\u00eatre constant et s\u00e9quelles peuvent \u00eatre inexistantes.  \n\nSi tous les segments de membre peuvent \u00eare atteints, il n'est pas exceptionnel d'observer des atteintes bifocales, en particulier un syndrome \u00e9paule-main. \n\n!!!!! DIAGNOSTIC TROP VITE POSE \n- Pied qui gonfle apr\u00e8s chir = normal \n- si \u00e7a va mieux puis regonfle = anormal \n\n"}}, {"id": 3, "contentCard": {"Q": "Diagnostic", "A": "1. Essentiellement CLINIQUE et trop souvent \u00e9voqu\u00e9 de mani\u00e8re abusive, sur une base iconographique. \n\n(2. BIOLOGIE )\n- standard : tjs normale (Calc\u00e9mie ok)\n- formes s\u00e9v\u00e8res : marqueurs remodelage possiblement \u00e9lev\u00e9s  mais faire DD !!!  : \n\tex : phosphatase alcaline ds ADSR post-fracturaire pfs imputable uniquement \u00e0 la fracture elle-m\u00eame\n\n(3. Rx STANDARD)\n\n4. SCINTIGRAPHIE OSSEUSE"}}, {"contentCard": {"Q": "Diagnostic Rx ()", "A": "-  essentielle, \n- mais asp\u00e9cifique et \"tardive\" par rapport \u00e0 la clinique. \n- os \"d\u00e9min\u00e9ralis\u00e9\" (mais trame ET min\u00e9ral diminu\u00e9s par le remodelage acc\u00e9l\u00e9r\u00e9), \n- struct h\u00e9t\u00e9rog\u00e8ne et  \"mouchet\u00e9e\", \n   MAIS corticales \u00e9pargn\u00e9e - du moins aux stades pr\u00e9coces (Figure 6). \n- interligne articulaire intact\n\n!!!  toute immobilisation prolong\u00e9e provoque d\u00e9min\u00e9ralisation radiologique, sans qu'il n'y ait n\u00e9cessairement une composante algique et \"inflammatoire\" anormale par rapport au trauma \n-> PAS ADSR apr\u00e8s trauma en l'absence d'une clinique compatible avec ce diag, m\u00eame si Rx avec signes de dystrophie osseuse. \n"}}, {"contentCard": {"Q": "Diagnostic : Scintigraphie osseuse ", "A": "\nVirtuellement toujours positive avant la radiologie :\n structures osseuses du segment atteint hypercaptent le traceur \n(m\u00e9thyl\u00e8ne- diphosphonate marqu\u00e9 au techn\u00e9tium 99m [MDP-99m-Tc]),\n->  T\u00e9moigne de l'hyperactivit\u00e9 ost\u00e9oblastique = remodelage ++ \n\nTechnique en 3 temps\n1  \"dynamique\" - imm\u00e9diatement apr\u00e8s l'embole - analyse le passage du traceur dans le r\u00e9seau vasculaire,\n2  \"pr\u00e9coce\"  : \u00e9tudie la distribution du traceur dans le milieu interstitiel\n3  \"tardif\", analyse la fixation osseuse ->  accroissement de la fixation osseuse tardive \n\t=  param\u00e8tre scintigraphique le + constant MAIS asp\u00e9cifique,  une restriction trop souvent oubli\u00e9e. \n\nNB : l'hyperfixation se met - non seulement dans l'espace fracturaire (= normal) \n\t\t- mais aussi \u00e0 distance"}}, {"contentCard": {"Q": "DD ", "A": "\nlarge : \n- Arthrite \n- Fissure (ou fracture) de stress : ++  pilon tibial et m\u00e9tatarsiens. \n\t- une fissure de stress, favoris\u00e9e par une OP corticale, peut se compliquer secondairement d'ADSR! \t- Ost\u00e9on\u00e9crose aseptique  dans l'ADSR de la hanche \n\n-> IRM : souveraine puisqu'en cas d'ADSR, le signal m\u00e9dullaire adipeux normal est remplac\u00e9e par un signal liquidien qui correspond \u00e0 la r\u00e9action \u0153d\u00e9mateuse osseuse"}}, {"id": 4, "contentCard": {"Q": "R/ ", "A": "PREVENTIF ++ \n- LIMITER au maximum l'IMMOBILISATION apr\u00e8s trauma \n- Kin\u00e9 : Eviter r\u00e9\u00e9ducation passive trop intensive. \n- Vit C \n\nCURATIF \n- soins \u00e9quipe pluridisciplinaire centr\u00e9e sur l\u2019algologie. \n- AINS,  gabapentine ou l\u2019amitryptyline  : composante inflammatoire et algique. \n- BIPHOSPHONATES : contr\u00f4le du remodelage osseux acc\u00e9l\u00e9r\u00e9\n\n(Capsulite r\u00e9tractile :)   injections intra- articulaires strictes de glucocortico\u00efdes retard\n\t phase algique r\u00e9solue -> r\u00e9\u00e9ducation prudente activo-passive toujours < seuil douloureux. \t\t\n\tphysioth\u00e9rapie utile  : ++ succession de bains chauds et froids. \n"}}]}, {"name": "Ost\u00e9on\u00e9crose aseptique", "contentChapter": [{"id": 0, "contentCard": {"Q": "D\u00e9finition\nLocalisation", "A": "Infarctus osseux \n-> mort de l'os\n-> risque fracturaire accru au nv de l'os trab\u00e9culaire \n-> l\u00e9sion corticale autour zone infarcie -> D+ \n\nHanche , genou "}}, {"id": 1, "contentCard": {"Q": "Etiologie", "A": "- Trauma \n- Glucortico\u00efdes \n- Alcool \n- Rare : \tSd antiphospholipide\n\tGaucher\n\tHIV\n\tLupus \u00e9ryth\u00e9mateux \n\tRadioT"}}, {"id": 2, "contentCard": {"Q": "Clinique", "A": "- Asympto : tant que pas d'effondrement au niveau de la lame osseuse sous chondrale\n- D+ hanche : atteinte lame osseuse \n- Arthrose secondaire "}}, {"id": 3, "contentCard": {"Q": "Diagnostic", "A": "IRM -> infarctus osseux visible"}}, {"id": 4, "contentCard": {"Q": "R/", "A": "- Pr\u00e9vention : \u00e9viter alcool , cortico\u00efdes ,..\n- Pas de R/ curatif \n- Marcher avec une canne\n- PTH ou PTG pfs"}}]}, {"name": "Patho abart. de la coiffe des rotateurs : p\u00e9riarthrite Scapulo-hum\u00e9rale", "contentChapter": [{"id": 0, "contentCard": {"Q": "D\u00e9finition", "A": "La p\u00e9riarthrite scapulo-hum\u00e9rale (PSH) \n\n = pathologie des tendons de la coiffe des rotateurs \n->  muscles \t- sus-\u00e9pineux  =  le \u00ab starter \u00bb de l'abduction de l'\u00e9paule. \n\t- sous-\u00e9pineux, \n\t- sous-scapulaire \n\t- petit rond. \nCes muscles \n- stabilisent l'articulation gl\u00e9no-hum\u00e9rale - en coaptant la t\u00eate hum\u00e9rale dans la gl\u00e8ne de l'omoplate -\n-  assurent la rotation de l'\u00e9paule : \n\t- rotation externe : sus-\u00e9pineux, sous-\u00e9pineux et petit rond\n\t- rotation interne : sous-scapulaire"}}, {"id": 1, "contentCard": {"Q": "PSH non-compliqu\u00e9e = simple \nClinique ", "A": "D+ du moignon - qui irradie g\u00e9n\u00e9ralement vers la face ant\u00e9rieure et externe du bras. \n\t- d\u00e9clench\u00e9e par le mouvement, surtout en fin de piste \n\t- limite les mouvements de l\u2019\u00e9paule. \n\t- d\u00e9cubitus ipsilat inconfortable : les patients ne dorment plus sur le c\u00f4t\u00e9 malade. "}}, {"contentCard": {"Q": "PSH non compliqu\u00e9e = simple \nDiag", "A": "Clinique g\u00e9n\u00e9ralement suffisante pour le diagnostic : \nD+ reproductible\n\t-  \u00e0 l'abduction contrari\u00e9es\t\t-> tendinites du sus-\u00e9pineux\n\t- la rotation externe contrari\u00e9es\t->     \"        \"       sous-\u00e9pineux\n\t- la rotation interne contrari\u00e9es\t->     \"        \"       sous-scapulaire\n\nRx de l'\u00e9paule :  - calcifications tendineuses  : loin d'\u00eatre constantes \n\t\t!!PAS de corr\u00e9lation en pr\u00e9s de calcification et patho tendineuse\n\t-  signes osseux indirects d'une tendinopathie d'insertion : \n\t\t= densification de l'os sous-chondral en regard de l'insertion tendineuse. \n\t- svt n\u00e9gatif !  mais permet d'exclure une \u00f4 pathologie de l'\u00e9paule. \n\nIRM, \u00f4 : si clinique persiste malgr\u00e9 R/ "}}, {"contentCard": {"Q": "PSH non compliqu\u00e9e= simple\nR/", "A": "- M\u00e9nagement transitoire et relatif de l'\u00e9paule\n- Kin\u00e9sith\u00e9rapie \n- Anti-inflammatoires : peu efficaces, action antalgique uniquement \n- Infiltration :  SI absence de r\u00e9ponse satisfaisante ou  r\u00e9apparition des plaintes \u00e0 l'arr\u00eat du R/ \n\t= 1 ou 2 injections de glucocortico\u00efdes retard, ( en intra- articulaire ) ou dans la bourse sous-acromio-\n\tdelto\u00efdienne !!! JMS dans le tendon  (provoquent tendinopathie)"}}, {"id": 2, "contentCard": {"Q": "PSH compliqu\u00e9e : 3 complications", "A": "- Epaule hyperalgique\n- Rupture coiffe des rotateurs\n- Capsulite r\u00e9tractile de l'\u00e9paule"}}, {"id": 3, "contentCard": {"Q": "PSH compliqu\u00e9e : Epaule hyperalgique", "A": "Etiologie : \t\u00e9clatement/ dissolution calcificat\u00b0 tendineuse dans les structures p\u00e9riarticulaires \n\t-> d\u00e9clenche une p\u00e9riarthrite microcristalline (par lib d'hydroxyapatite) tr\u00e8s inflammatoire\n\nClinique  : \tD+ \tbrutale et tr\u00e8s s\u00e9v\u00e8re de l'\u00e9paule \n\t \tsans contexte traumatique\n\tAvec impotence fonctionnelle totale : mobilisation active et passive impossible. \n\t\tLe patient immobilise le membre malade par le bras oppos\u00e9\n\nDiag : \tClinique \n\tRx : \tcalcificat\u00b0 avec densit\u00e9 parfois floue car dissolution r\u00e9cente\n\nR/  urgence rhumatologique \n- immobilisation, \n- glace\n- anti-inflammatoires \n- injection intra-articulaire (sous acromiale ??) de glucocortico\u00efdes retard. \n\nNB : S\u00e9dation de la douleur g\u00e9n\u00e9ralement aussi rapide que l'acuit\u00e9 de son installation. "}}, {"id": 4, "contentCard": {"Q": "PSH compliqu\u00e9e : Rupture coiffe des rotateurs", "A": "Elle peut \u00eatre partielle ou compl\u00e8te. \n\nEtiologie : \t\ntraumatique: \t= PAS une complication de la PSH , patients jeunes\n\t= csq  d'un mouvement violent ou d'une chute sur le bras tendu.\n\tClinique \tD+ aigu\u00eb et intense\n\tExam clin\tmobilit\u00e9 \n\t\t- passive:  normale (mais douloureuse), \n\t\t- active : abd et rotat\u00b0 externe - surtout contre R-  irr\u00e9alisables ds ruptures totales\n\t\t- maintien abd \u00e0 90\u00b0 possible gr\u00e2ce au muscle delto\u00efde (ne sait plus la d\u00e9buter)\n\t\tH\u00e9matome peut appara\u00eetre au niveau du bras dans h-j qui suivent la rupture. \n\tR/ \tchirurgical, du moins chez les sujets jeunes avec une rupture compl\u00e8te. \n\ntrophique : \t = complication dans le d\u00e9cours d'une vieille PSH, patients ag\u00e9s\n\tClinique\t insidieuse \n\t\td+ chroniques de l'\u00e9paule \n\t\tlimitation fonctionnelle progressive. \n\tExam clin.\t moins informatif car chronicit\u00e9 -> m\u00e9canismes compensatoires. \t\t\t\t\tsi rupture compl\u00e8te ->  amyotrophie correspondante. \n\tR/ \tKin\u00e9\t\n\n(Diag formel  )\n- Arthrographie : le liquide inject\u00e9 par voie intra-articulaire p\u00e9n\u00e8tre dans la bourse sous-acromio-\n\tdelto\u00efdienne car lors de la rupture de la coiffe, la capsule articulaire, fortement adh\u00e9rente, se d\u00e9chire. - Echo et arthroscanner : peuvent montrer une rupture tendineuse \n- Rx standard: - ascension de la t\u00eate hum\u00e9rale lors de l'abduction contrari\u00e9e (man\u0153uvre de Leclerc) \n\t- diminution de la hauteur du d\u00e9fil\u00e9 acromio-hum\u00e9ral. \nEn cas d'ascension chronique de la te\u0302te hume\u0301rale, on peut observer une ne\u0301o-articulation acromio-hume\u0301rale. "}}, {"id": 5, "contentCard": {"Q": "PSH compliqu\u00e9e : Capsulite r\u00e9tractile de l'\u00e9paule", "A": "= fibrose de la capsule articulaire gl\u00e9no-hum\u00e9rale \n\nEtiologie : \tcomplication chronique d'une PSH n\u00e9glig\u00e9e.\n\nClinique\tCoaptation trop serr\u00e9e de la t\u00eate hum\u00e9rale dans la cavit\u00e9 gl\u00e9no\u00efde\n\t->  diminue les possibilit\u00e9s fonctionnelles de l'\u00e9paule qui est dite \u00ab gel\u00e9e \u00bb \n\tLimititation mobilit\u00e9 ACTIVE et PASSIVE\n\nR\u00e9duction \n- amplitude de tous les mouvements  :  non tant par la douleur que par un d\u00e9ficit m\u00e9canique pur. \n- volume de l'articulation  : une \u00e9paule gel\u00e9e n'accepte que quelques ml  de produit de contraste \u00e0 l'arthrographie (au lieu de 10 \u00e0 15 ml normalement). \n\nRx  : \trar\u00e9faction de la trame osseuse li\u00e9e \u00e0 un manque de mobilisation de l'\u00e9paule. \n\nR/ \tplusieurs injections intra-articulaires de glucocortico\u00efdes retard \n\tKin\u00e9 (mobilisation active et passive) toujours < seuil douloureux. U\n\nEvolution \tsvt  favorable moyennant un traitement prolonge\u0301"}}]}, {"name": "Syndrome du canal carpien", "contentChapter": [{"id": 0, "contentCard": {"Q": "D\u00e9finition\nEtiologie", "A": "R\u00e9sulte de la compression du nerf m\u00e9dian dans le tunnel carpien.\n\nPuisque ce canal est inextensible, toute augm de la P intracanalaire provoque une neuropathie d'enclavement. \n\n\n\t\nIdiopathique 80% !! \n\nFormes \"secondaires\" les plus fr\u00e9quentes  : \n\t\t- \"microtraumatiques\",\n\t\t-  grossesse (T3) \n\t\t- rhumatismes inflammatoires. \n\nCauses traumatiques \tFractures du poignet \n\t\tEntorses du poignet \n\t\tContusions du poignet \n\nCauses microtraumatiques \tProfessionnelles \t\n++++\t\tSportives \n\t\tOccasionnelles \n\nCauses inflammatoires \tT\u00e9nosynovites des fl\u00e9chisseurs du poignet (PR, infection)  \n++++\t\tTendinite\n\nCauses endocriniennes \tHypothyro\u00efdie (d\u00e9p\u00f4t sub myxo\u00efde)\n\t\tAcrom\u00e9galie (os trop gd) \n\nCauses infiltratives \t\u0152d\u00e8me (3e trimestre de la grossesse)  +++\n\t\tAmylose \n"}}, {"id": 1, "contentCard": {"Q": "Clinique", "A": "FORME SENSITIVE\nAcroparesth\u00e9sies , dysesth\u00e9sies et endormissements des doigts : \n- doigts malhabiles, engourdis et parfois suffisamment gonfl\u00e9s pour que les patients retirent leurs bagues\n- plus souvent au niveau de tous les doigts qu'au niveau des trois premiers rayons \n\tterritoire : pouce index majeur face radiale annulaire\n- irradient fr\u00e9quemment vers les coudes\n- survenant classiquement \t- la nuit  !! (r\u00e9veille le patient)\n\t\t- ou parfois en tenant le cornet du t\u00e9l\u00e9phone (signe du t\u00e9l\u00e9phone). \n-  reproductibles par 2 manoeuvres : \n\t- Phalen (flexion du poignet sur les avant-bras, eux-m\u00eames en appui sur les coudes)\n\t- Tinel (percussion de la face palmaire du poignet) \n\nComplication : formes s\u00e9v\u00e8res : \n- hypoesth\u00e9sie dans le territoire du nerf m\u00e9dian,\n- par\u00e9sie des muscles concern\u00e9s \n- amyotrophie de l'\u00e9minence the\u0301nar. \n= FORME MOTRICE "}}, {"id": 2, "contentCard": {"Q": "Diagnostic", "A": "- Diagnostic clinique \n- EMG : svt mais pas indispensable : tps de conduction \u00e9lectrique/de latence distale nerf m\u00e9dian (> 4,5 msec). "}}, {"id": 3, "contentCard": {"Q": "R/ ", "A": "MEDICAL : Le seul efficace = inject\u00b0 intracanalaire (e. tendons du petit et grand palmaire) de glucocortico\u00efdes\n\t-> dim oed\u00e8me \n\t-> d\u00e9compression n.m\u00e9dian\n\nCHIRURGIE  :  section du ligament annulaire ant\u00e9rieur du carpe SSI\n\t- \u00e9chec ou r\u00e9cidives trop rapides au traitement m\u00e9dical \n\t- travailleurs manuels (d'office r\u00e9cidive)\n\t- les + \u00e9volutifs : atteinte motrice =indication chir absolue (clinique ou EMG) \n\t- les plus \u00e9volutifs, y compris \u00e9lectriquement.\t"}}, {"contentCard": {"Q": "DD", "A": "- compression arthrosique d'une racine cervicale (radiculalgie C6)"}}]}, {"name": "Arthrose", "contentChapter": [{"id": 0, "contentCard": {"Q": "D\u00e9finition", "A": " = affection rhumatismale la plus fr\u00e9quente. \n\nMaladie de\t- cartilage\n\t- membrane synoviale\n\t- os sous-chondral\n\nN'EST PLUS consid\u00e9r\u00e9 comme csq in\u00e9vitable et incurable du vieillissement\nMAIS PLUTOT comme un processus m\u00e9taboliquement dynamique fait de destruction du cartilage et de tentative de reconstruction (r\u00e9paration osseuse) \n->  susceptible d'\u00eatre modul\u00e9 ds les prochaines d\u00e9cennies par la th\u00e9rapeutique. \n\nCartilage \t- tissu aux propri\u00e9t\u00e9s biom\u00e9caniques remarquables \n\t- \u00e9labor\u00e9 par les chondrocytes : synth\u00e9tisent\n\t\t- coll type II organis\u00e9 en r\u00e9seau -> r\u00e9sistance \u00e0 la traction \n\t\t- gel aqueux de prot\u00e9oglycans -> nutrition et r\u00e9sistance \u00e0 la pression. \n\nStades pr\u00e9coces de l\u2019arthrose, les chondrocytes prolif\u00e8rent, augmentent leur synth\u00e8se de matrice extracellulaire et leur production d\u2019aggr\u00e9can.(certaines \u00e9tudes disent que le cart s'\u00e9paissit ! )  \n\nNB : cartilage non vascularis\u00e9 , se nourrit gr\u00e2ce \u00e0 l'aggr\u00e9can via mobilisation du cart (-> activit\u00e9 phys! ) \n\nPrimum movens discut\u00e9 : \t- rupture du r\u00e9seau collag\u00e9nique\n\t\t- d\u00e9pl\u00e9tion en PG\n\t\t- perturbation de la fonction des chondrocytes\n\t\t- maladie de l\u2019os sous-chondral.\n\n"}}, {"contentCard": {"Q": "Physiopathologie\nEtiologie", "A": "Physiopatho de mieux en mieux connue. \n\nFACTEURS GENETIQUES :  tr\u00e8s rares formes d\u2019arthrose pr\u00e9coces, s\u00e9v\u00e8res et familiales, dues \u00e0 des mutations dans des g\u00e8nes du collag\u00e8ne de type II, ...  -> en particulier arthrose DIGITALE\n\nFACTEURS MECANIQUES :  fr\u00e9quents, augm contraintes\n\t- atcd m\u00e9niscectomie \t(perte amortisseur)\n\t- fracture mal r\u00e9duite \t(axe incorrect)\n\t- ost\u00e9on\u00e9crose aseptique\n\t- maladie de Paget \t(modif anat) \n\nMALADIES METABOLIQUE : fragilisent cart \n\t- h\u00e9mochromatose\t(d\u00e9pot h\u00e9mosid\u00e9rine dans cart)\n\t- acrom\u00e9galie \n\t- chondrocalcinose \t= pseudo goutte ds arthrite microcristalline \n\t\t\t(cristaux d'hydroxyappatite)  \n\t- Ob\u00e9sit\u00e9 !!! : pas uniquement facteurs m\u00e9caniques , adipocytokines \n\nFACTEURS INFLAMMATOIRES :\n\t- interleukine-1, \n\t-  m\u00e9talloprot\u00e9inases matricielles (MMP) (dont la collag\u00e9nase) \n\t- peptidases ADAMTs  -> fragmentation aggr\u00e9can par peptidases en peptides proinflam\n\n\t\t             ->  activation de la cascade du compl\u00e9ment.\nOBESITE  :  \t- contraintes m\u00e9caniques \n\t- lib\u00e9ration accrue d\u2019adipocytokines -> r\u00f4le proinflammatoire"}}, {"id": 1, "contentCard": {"Q": "Localisation ", "A": "- Toutes les articulations peuvent \u00eatre atteintes\n-  Pas de corr\u00e9lation entre les d\u00e9g\u00e2ts anatomiques et les plaintes subjectives et fonctionnelles \n\nlocalisation les + fr\u00e9quentes : mains et rachis \n\n\tLocalisations fr\u00e9quentes \t\tLocalisations plus rares \n\nMS \ttrap\u00e9zom\u00e9tacarpienne = pouce\tMCP \n\tIPP  rare\t\t\tpoignet , coude,..\n\tIPD ++++ \t \t\t\u00e9paule (sauf acromioclav)\n\nMI\thanche\t\t\tcheville \n\tgenou ++++\n\t1\u00e8re MTP (hallux rigidus)\n\nRachis \tcolonne cervicale \n\tcolonne lombaire \n\n\n\n"}}, {"id": 2, "contentCard": {"Q": "Arthrose digitale = polyarthrose", "A": "++ F\u00ea \n>  40 ans\nIPD et IPP\nImpact fonctionnel faible car MCP rarement atteinte -> on garde la pince \n\nIPD et IPP  : 2 phases\t\n1. D+\n\n2. Nodosit\u00e9s \td'Heberden  :  IPD ++\n                  \tde Bouchard :  IPP\n\n      \t= ost\u00e9phytes de la taille d'un grain de riz\n\tsitu\u00e9es de part et d'autre des art.\n\n\tsubissent des pouss\u00e9s fluxionnaires\n\t\t-  parfois tr\u00e8s algiques\n\t\t- avec rougeur, chaleur et gonflement. \n\n\tAu bout de quelques mois : Mains noueuses\n\t\t- r\u00e9gress\u00b0 ph\u00e9nom\u00e8nes inflamm : pas de D+\n\t\t- mais persistance les nodosit\u00e9s \n\t\t- et possible subluxation des phalangettes \t\t\n\t-> inesth\u00e9tiques, mais fonction reste tr\u00e8s longtemps bien conserv\u00e9e. \n\nMCP\n- + rare.\n- fr\u00e9quente dans l'h\u00e9mochromatose dont elle est parfois le signe r\u00e9v\u00e9lateur "}}, {"id": 3, "contentCard": {"Q": "Rhizarthrose du pouce", "A": "= articulation trap\u00e9zom\u00e9tacarpienne \n\n1. D+ \t- de la base du pouce \n\t- de rythme m\u00e9canique \n\t- provoqu\u00e9es par des efforts - de serrement \n\t\t\t- ou de pincement. \n\n2 .Possible associat\u00b0 \u00e0 une t\u00e9nosynovite de Quervain\n\n3. Apparition progessive d'une saillie de la base du premier m\u00e9tacarpien (racine pouce)"}}, {"contentCard": {"Q": "Coxarthrose\nClinique \n- Anamn\u00e8se\n- Examen clinique", "A": "++ H\u00f4 \n\nD+ \t- pli inguinal + face ant de la cuisse (plus rarement de la fesse) \n\t- M\u00e9canique\t\u00e0 la mise en route apr\u00e8s position assise \n\t\t\u00e0 la marche, limitant son p\u00e9rim\u00e8tre\n\t- Pi\u00e8ges ! \tD+ hanche pour le patient = svt douleurs lombo-fessi\u00e8res \n\t\t\tou de cr\u00eate iliaque d'origine rachidienne. \n\t\tD+ r\u00e9f\u00e9r\u00e9es au genou +++ -> tjs faire examen hanche lors de gonalgies \n\nHandicap \t- peut \u00eatre tr\u00e8s important car hanche = articulation portante essentielle\nfctionnel \t- d\u00e9marche saluante (car d\u00e9ficit d'extension de la cuisse vers le bassin).\n\t- gestes de la vie quotidienne g\u00e9n\u00e9s (lacer chaussures, enfiler chaussettes,\n\t\t\t\t s'asseoir sur si\u00e8ge bas,  monter escalier)  \n\nSignes de tendinopathie associ\u00e9e (Bursite trochant\u00e9rienne secondaire par compensation)  \n\n\nExamens en d\u00e9cubitus dorsal et ventral\n\t- amplitude des mouvements r\u00e9duite\n\t- atteinte \tpr\u00e9coce +++ extensions, rotation interne et externe \n\t\tbeaucoup plus tardive de la flexion, longtemps conserv\u00e9e. \n\t- amyotrophie quadricipitale fr\u00e9quente. \n\t-  D+ \u00e0 la pression du creux inguinal, en dehors de l'a. f\u00e9morale\n\nFormes s\u00e9v\u00e8res  - difficult\u00e9s \u00e0 l'appui monopodal \n\t- attitude antalgique en flexion, adduction et rotation externe avec hyperlordose compensatoire. "}}, {"contentCard": {"Q": "Coxarthrose \nEtiologies", "A": "Les e\u0301tiologies des coxarthroses secondaires dues a\u0300 des malformations architecturales diverses, comme la malformation subluxante, sont de\u0301crites en orthope\u0301die. \n\n"}}, {"contentCard": {"Q": "Coxarthrose \nDiagnostic ", "A": "1. CLINIQUE\n\n2. Confirmation par RX \n- pincement de l'interligne articulaire - le plus souvent sup\u00e9ro-externe - \n- ost\u00e9oscl\u00e9rose et g\u00e9odes sous- chondrales \n- ost\u00e9ophytose f\u00e9morale (en collerette p\u00e9ricapitale) et cotylo\u00efdienne \n\n+ : \n- identifier les anomalies anatomiques \u00e9ventuellement responsables de la coxarthrose \n- \u00e9carter \u00f4 diag \t- ost\u00e9on\u00e9crose t\u00eate f\u00e9morale\n\t\t- coxopathie pag\u00e9tique\n\t\t- m\u00e9tastases \n\t\t- algodystrophie hanche"}}, {"contentCard": {"Q": "Coxarthrose\nEvolution", "A": "\n\nTRES VARIABLE d'un patient \u00e0 l'\u00f4  : \n- Lente ++\t\tplusieurs ann\u00e9es pour que \n\t\t- la d+ - d'abord calm\u00e9e par le repos - finisse par s'exacerber la nuit \n\t\t\t\t\t         et r\u00e9veiller le patient, \n\t\t- l'attitude vicieuse s'accentue \n\t\t- le handicap fonctionnel devienne important\n\n- Pas d'\u00e9volution pfs \tet reste remarquablement bien contr\u00f4l\u00e9e\n\n- Rapide : CDR \t= coxarthrose destructrice rapide \n\t\tdestruction hanche en quelques mois\n\t\t!!! Ob\u00e9sit\u00e9\n\t\tFacteur d\u00e9clanchant = trauma\n\nChondrocalcinose ? pseudo goutte : aussi \u00e9volution rapide de l'arthrose"}}, {"contentCard": {"Q": "Gonarthrose", "A": "F\u00ea ++ \n\n2 formes : f\u00e9moro-tibiale et f\u00e9moro-patellaire\n\nCommun aux 2 formes : \n\nHYDRARTHROSE  = \u00e9panchement art. \u00e9pisodique de nature m\u00e9canique (diff entre liq m\u00e9c et infl v.JS)\n\nCommunication physiologique entre cavit\u00e9 art. et bourse s\u00e9reuse du creux poplit\u00e9 \n-> collection de liquide articulaire progressive dans la bourse\n\nM\u00e9canisme de clapet \n-> le liquide - une fois rentr\u00e9 dans la bourse s\u00e9reuse - ne peut s'en \u00e9chapper\n-> KYSTE POPLITE OU DE BAKER\n\tEtiologies : \tToutes les affections du genou s'accompagnant d'une hydarthrose \n\t\tmais +++  gonarthrose et PR \n\tClinique : \tasymptom (d\u00e9couverte clinique, \u00e9cho ou arthrographique \"fortuite\") \n\t\tou D+  creux poplit\u00e9 \n\t\tou compression du nerf sciatique poplit\u00e9 externe. \n\n\tComplication : RUPTURE du kyste dans le mollet \n\t\t-> syndrome douloureux + impotence fonctionnelle aigus \n\t\tpseudo-phl\u00e9bite !!  (faire DD avec phl\u00e9bite car ressemble ++) \n\t\t- tum\u00e9faction d+ du mollet, \n\t\t- \u0153d\u00e8me de la jambe, de la cheville et du pied \n\t\tMAIS complication de la rupture = thrombophl\u00e9bite vraie par compression des \n\t\t\t\ttroncs veineux jambiers ! \n\tR/\tR/ de l'arthropathie du genou sous- jacente. "}}, {"contentCard": {"Q": "Gonarthrose\nArthrose f\u00e9morotibiale", "A": "pr\u00e9domine souvent au niveau d'un des deux compartiments f\u00e9moro-tibiaux (externe ou interne), \n\nEtiologie ++ secondaire : \n\t- d\u00e9g\u00e9n\u00e9rescence m\u00e9niscale post-traumatique,\n\t- m\u00e9nisectomie \n\t- d\u00e9viation axiale en valgus : atteinte du compartiment externe\n\t\t ou en varus  : atteinte du compartiment interne\n\nClinique  :\t- gonalgies m\u00e9caniques\t rythm\u00e9es par la marche  \n\t\t\tcalm\u00e9es par le repos.\n\t- hyperextension limit\u00e9e beaucoup plus pr\u00e9cocement que la flexion. \n"}}, {"contentCard": {"Q": "Gonarthrose \nArthrose f\u00e9moro-pattelaire", "A": "\nEtiologie\t++ Primaire : plus souvent structurale  \n\n\tSecondaire :   subluxation externe de la rotule par rapport \u00e0 la trochl\u00e9e f\u00e9morale favorise \n\t\tl'apparition de l\u00e9sions d\u00e9g\u00e9n\u00e9ratives du cartilage dont la chondromalacie de la \n\t\trotule serait - chez le patient plus jeune - le premier stade anatomique. \n\n-> Arthrose f\u00e9moro- patellaire et chondromalacie rotulienne = m\u00eame clinique :SD ROTULIEN\n\n\nD+ \t ant\u00e9rieur qd rotule plaqu\u00e9e\n\t\t- mont\u00e9e et de la descente des escaliers\n\t\t- position assise prolong\u00e9e (douleur ant). \n\thyperextension du genou\n\tmobilisation de la rotule sur la trochl\u00e9e (signe du rabot)\n\tpalpation de la face post\u00e9rieure de la rotule sublux\u00e9e"}}, {"contentCard": {"Q": "Gonarthrose\nDiagnostic", "A": "confirm\u00e9e par Rx comprenant une incidence f\u00e9moro-patellaire. "}}, {"contentCard": {"Q": "R/ Arthrose p\u00e9riph\u00e9rique ", "A": "But :\t- am\u00e9liorer d+ et fonction locomotrice\n\t- limiter la progression du dommage structural\n\t- ne pas nuire  !! (ex : AINS chez p.ag\u00e9es bcp + susceptibles de subir ES : hrg dig,..) \n\nSuivi R/ : \tQuestionnaire WOMAC corr\u00e8le bien avec intensit\u00e9 de la plainte \n\nMesures g\u00e9n\u00e9rales\n \t- informer les patients : lentement \u00e9volutive, non mortelle\n\t- perdre du poids \n\t- entretenir musculature (en particulier les quadriceps) pr \u00e9viter sarcop\u00e9nie, atrophie\n\t\t-> exercice physique\n\t\t-> kin\u00e9 \n\t- aides m\u00e9caniques :\n\t\t-> canne si MI atteint du cot\u00e9 oppos\u00e9 au cot\u00e9 atteint\n\t\t-> attelles (ex : racine du pouce)\n\nM\u00e9dical\n\t- antalgiques simples -> Parac\u00e9tamol = reste le R/ de base de l'arthrose (max 3g/j) \n\t- \u00e9viter  AINS (sauf si occasionnel : p\u00e9riode hyperlagiques)\n\t             Morphinique : Tramadol (Danger P.ag\u00e9es : Vertiges -> chute -> fracture!)\n\t\t            Durog\u00e9sic, Oxycontin (NON ! uniquement courte dur\u00e9e -> pas arthrose) \n\nGonarthrose s\u00e9v\u00e8re avec \u00e9panchement important du genou  : \n\t- pct\u00b0 \n\t- injection solution de glucocortico\u00efdes retard ds l'articulation  \n\t\t-> liq revient moins vite mais aucun effet structural\n\nDe fond : \tPas encore ayant fait preuves d'efficacit\u00e9  : \t\n\t- viscosuppl\u00e9mentation \n\t\tInjection intra-art d'acide hyaluronique (huiler art.) sur un genou sec \n\t\t\t\t+ un peu de cortico\u00efdes\n\t\t++ orthop\u00e9diste mais rhumato n'y croit pas \n\t\tEffet placebo important (surtt avec aiguille + cher !)\n\t\tAction antalgique mais pas sur la progression du dommage structural. \n\n\t- suppl\u00e9ments alimentaires : sulfate de glucosamine et de chondro\u00eftine, \n\t\tsvt utilis\u00e9s comme auto-m\u00e9dicat\u00b0 (am\u00e9liore PAS, mais coute cher -> placebo) \n\t\tPAS de preuve de leur efficacit\u00e9 (commerce ++)\n\n\t- greffe de cellules souches m\u00e9senchymateuses : les patients demandent mais exp\u00e9riment\n\t\tSauf cas particulier sportif : rupture cart traumatique \n\n\t- Ac monoclonal contre NGF : \u00e9tude clinique fct am\u00e9lior\u00e9e antid+  mais d\u00e9struct\u00b0 + rapide de \t\t\t\tl'articulation\n\nChirurgie : \t\n\t- Ost\u00e9otomie de correction : stade pr\u00e9coce !\n\t- PTH et PTG : miracle !  Quand le handicap fonctionnel est majeur\n\n!! On op\u00e8re pas une radio  : si patient asympto, ou adapte vie au handicap on op\u00e8re pas !!\n\t"}}, {"contentCard": {"Q": "Cervicarthrose \nClinique\nLocalisation", "A": "\n- Universelle radiologiquement au-del\u00e0 de l'\u00e2ge de 40 ans mais souvent ASYMPTO\n- peut se manifester par des NUCALGIES\n\t- parfois aigu\u00ebs compliqu\u00e9es de blocage cervical (torticolis) \n\t- + fr\u00e9quemment chroniques ne limitant que tardivement la mobilit\u00e9 de la nuque. \n\nLocalisations 3 articulation  : \n- discarthrose = ant\n\tatteinte d\u00e9g\u00e9n\u00e9rative du disque intervert et des plateaux cartilagineux vert\u00e9braux \n\tassoci\u00e9e \u00e0 une ost\u00e9ophytose r\u00e9actionnelle\n\tsi\u00e8ge ++ aux segments inf\u00e9rieurs, en particulier C5-C6 \n\n- arthrose interapophysaire  = post\n\tsi\u00e8ge aux niveaux sup\u00e9rieurs\n\n- uncarthrose = d\u00e9finissent trous de conjugaison\n\tau niveau des apophyses unciformes \n\nLes 2 derniers peuvent r\u00e9tr\u00e9cir les trous de conjugaison "}}, {"contentCard": {"Q": "Cervicarthrose \nDD nucalgies ", "A": "\nDD large !! \n\t- discites infectieuses, \n\t- tumeurs rachidiennes, de la fosse post\n\t- atteinte inflammatoire du rachis cervical (PR)\n\t- cervicalgies posturales de l'adulte jeune: \n\t\t++ femmes avec profession (secr\u00e9tariat, bureautique) n\u00e9cessitant postures \n\t\tprolong\u00e9es de la t\u00eate pench\u00e9e en avant. \n\t\t-> clinique : contracture des muscles trap\u00e8zes ++++ "}}, {"contentCard": {"Q": "Cervicarthrose non compliqu\u00e9e\nR/", "A": "\nR/ conservateur : \n- port d'un collier cervical, \n- antalgiques,\n- AINS occasionnellement, \n- massages myorelaxants \n- chaleur locale. "}}, {"contentCard": {"Q": "Cervicarthrose \nComplications", "A": "NEVRALGIE CERVICOBRACHIALE \nEtiologie \t= compression radiculaire par : \t \n\t-  ++  uncarthrose floride r\u00e9tr\u00e9cissant le trou de conjugaison, \n\t- plus rare :  hernie ou protrusion discale (>< sciatique ++ caus\u00e9e par hernie discale lombaire)\n\nD+\tpart de la nuque\n\tirradie vers scapula, \u00e9paule, bras, avant-bras , doigts en fonction niveau radiculaire concern\u00e9\n\texacerb\u00e9e par mvt de nuque\n\tsouvent tr\u00e8s intense \n\thabituellement nocturne. \n\nR/ \timmobilisation par une minerve rigide, l\n\tantalgiques et d'anti-inflammatoires puissants\n\t injections p\u00e9ridurales cervicales de glucocorticoi\u0308des. \n\nnon d\u00e9crites: \nNEVRALGIE D'ARNOLD \nMYELOPATHIE  : rare, compression - et/ou isch\u00e9mie - m\u00e9dullaire cervicale\n\t\t->  parapar\u00e9sie ou une parapl\u00e9gie, voire une t\u00e9trapar\u00e9sie ou une t\u00e9trapl\u00e9gie. \t\tR/  chirurgical dans les cas franchement symptomatiques. "}}]}, {"name": "Goutte", "contentChapter": [{"id": 0, "contentCard": {"Q": "D\u00e9finition\nEtiologie et complications ", "A": "= une des complications de l'hyperuric\u00e9mie chronique (> 10 ans)  \n\n\u00f4 complications de l'hyperuric\u00e9mie (voir + loin ds les fiches )\n- TOPHUS : d\u00e9p\u00f4ts cutan\u00e9s et visc\u00e9raux \n- COMPLICATION RENALE : lithiases\n- ASSOCIATION ++ SYND METABOLIQUE\n- FdR cardiovasculaire"}}, {"id": 1, "contentCard": {"Q": "Hyperuric\u00e9mie\nPhysiopathtologie , valeurs ", "A": "acide urique =  produit final du catabolisme des purines \n- Nous sommes incapable de m\u00e9taboliser l'urate (ex : oiseaux avec uricase)  ->\u00e9limination ++ par les rein \n- Xanthine oxydase : m\u00e9tabolisme de la xanthine (<ad\u00e9nine et guanine) en acide urique \n\nPool miscible de l'acide urique tr\u00e8s faible  : jms > 1g  (sauf chez le goutteux o\u00f9 il peut atteindre 25 g !) : 65% de l'acide urique du pool se renouvelle quotidiennement. \n\nEntr\u00e9es : \t- 10 % des purines < alimentation (aliments riches en cellules) \n\t- 90 %  < de la synth\u00e8se de novo (libir\u00e9 par le catabolisme de nos cellules) = ORIGINE ENDOGENE \n\nSorties : \t- 1/3 de l'acide urique form\u00e9 \u00e9limin\u00e9 dans l'intestin \n\t- 2/3 par les reins \t- filtration glom\u00e9rulaire, \n\t\t\t- r\u00e9absorption tubulaire proximale via transporteur URAT-1 (entre autres)\n\t\t\t- passage par le p\u00f4le basolat\u00e9ral \n\t\t\t- s\u00e9cr\u00e9tion tubulaire\n\t\t -> \u00e9liminer quotidiennement entre 300 et 600 mg d'urate. \n\t\t-> Rein r\u00f4le pr\u00e9pond\u00e9rant dans hom\u00e9ostasie uratique\n\nUric\u00e9mie moyenne (\u00b1 d\u00e9viation standard)  :  5,1 \u00b1 1 mg/dl chez l'homme adulte \n\t\t\t4,0 \u00b1 1 mg/dl chez la femme adulte. \n- plus basse (< 4 mg/dl) avant la pubert\u00e9 gar\u00e7on et fille  \n- apr\u00e8s MNP,  femme tend \u00e0 se rapprocher de celle de l'homme. \n\nUric\u00e9mie pathologie : \t> 7 mg/dl (soit 420 \u03bcmole/l) chez l'homme \n\t\t> 6 mg/dl (soit 360 \u03bcmole/l) chez la femme. \n\t! bcp de patients avec valeurs patho sans crises de goutte -> ne pas R/ d'embl\u00e9e\n\t\t\t\t\t-> ne pas \u00ea obnibul\u00e9 par huric\u00e9mie dvt toute patho articulaire\n\nConsid\u00e9ration physico-chimiques  :  produit de solubilit\u00e9 de l'urate monosodique se situe aux environs de 7 mg/dl (\u00e0 37\u00b0C). \n\t\t\t!! Cible th\u00e9rapeutique + basse\n\t\t! diminution solubilit\u00e9  : \t- pH acide \n\t\t\t\t- dim T\u00b0  (extr\u00e9mit\u00e9 35\u00b0) \n\n\n\n-> format\u00b0 cristaux d'urate -> pr\u00e9cipitation \t- art (goutte)\n\t\t\t\t\t\t\t- tissus mous (tophus : surtout aux extr\u00e9mit\u00e9s) \n\t\t\t\t\t\t\t- urines (lithiases urinaires) \n\t\t\t\t\t\t\t"}}, {"contentCard": {"Q": "Hyperuric\u00e9mie \nEtiologie", "A": "\nParfois ce peut \u00ea les 2 \u00e0 la fois : \n\nPurinosynth\u00e8se excessive \t\n- G\u00e9n\u00e9tiques\n\n- Acquises : \tH\u00e9molyse chronique\n\n\tTurn-over cellulaire acc\u00e9l\u00e9r\u00e9  : \n\t- R/ chimioT cytostatique  : synd de lyse tumorale\n\t- H\u00e9mopathies malignes\n\n\tConsommation importante : seul 10% des urates sont d'origines exog\u00e8ne ! \n\t- de bi\u00e8re  : ++ levures -> ++ cellules -> ++ purines\n\t- de soda  : ++ fructose phosphoyl\u00e9 -> conso ATP et prod AMP -> ad\u00e9nine-> xanthine-> urate\n\t- pas de vin !!\n\nDiminution de l\u2019\u00e9limination r\u00e9nale des urates +++++\n- G\u00e9n\u00e9tiques \tD\u00e9fects g\u00e9n\u00e9tiques : transportosome des urates = CAUSE N \u00b01\n\n- Acquises \tIRA et IRC m\u00eame peu s\u00e9v\u00e8res  = SITUATION CLINIQUE LA PLUS FREQUENTE \n\tDiur\u00e9tiques (inhibent la s\u00e9cr\u00e9tion tubulaire d\u2019urates) sauf spironolactone \n"}}, {"contentCard": {"Q": "Hyperuric\u00e9mie\nClinique", "A": "rarement symptomatique : moins de 20 % des hyperuric\u00e9miques deviendront des goutteux. \n\nCondition pour goutte : hyperuric\u00e9mie \n- suffisamment importante \n- et/ou suffisamment prolong\u00e9e\n\thyperuric\u00e9mie -> d\u00e9p\u00f4t uratique -> manif art. :  exige en g\u00e9n\u00e9ral 10 ans d'hyperuric\u00e9mie !  \n\nhyperuric\u00e9mie fr\u00e9quente et goutte relativement rare  (surtt f\u00ea) \n-> NE PAS poser trop rapidement diag de goutte chez un patient hyperuric\u00e9mique qui souffre de D+ art ou d'IR \n\nPr\u00e9cipitation des cristaux d'urate \n- articulations -> goutte \n- tissus mous -> tophus (++ extr\u00e9mit\u00e9s) \n- urines -> lithiases urinaires\n"}}, {"contentCard": {"Q": "Crise de goutte\nPhysiopathologie ", "A": "La crise de goutte est le paradigme de l'arthrite - et parfois de la bursite ou de la te\u0301nosynovite - inflammatoire. \n\nGoutte  = maladie m\u00e9di\u00e9e par l\u2019inflammasome et l\u2019IL1\u03b2 \n\tcristaux d\u2019urates monosodique recouverts de prot\u00e9ines (Ig ) \n\t-> activation inflammasome :  NALP3 (cryopyrine)\n\t-> activation de la caspase-1 \n\t-> clivage de la pro-IL1\u03b2 en IL1\u03b2 = cytokine tr\u00e8s importante dans sys imm inn\u00e9"}}, {"contentCard": {"Q": "Crise de goutte \nClinique", "A": "MONOarthrite clinique caricaturale ! \n- ++ 1\u00e8re MTP = m\u00e9tatarso-phalangienne de l'hallux (= podagre)\n- cheville\n- tarse\n- genou \n -ou de toute autre articulation\n\nProdrome possible \t- malaise g\u00e9n\u00e9ral \n\t\t-  paresth\u00e9sies dans le territoire concerne\n\t\t-> avoir colchicine en poche pour la prendre en cas de prodrome ! \n\nD\u00e9but : \tpicotements\n\n2-3h : \tD+ \tD\u00e9but ++ fin de nuit\n\t\trapidement maximales, atroces et pulsatiles\n\t\tLe patient ne supporte plus le poids du drap de lit sur son orteil. \n\n\tImpotence fonctionnelle totale :\n\t\tl'appui sur le pied atteint impossible\n\t\tpatient est incapable de se chausser. \n\n\tT\u00b0 \tpas rare\n\n\tExam \t1\u00e8re MTP gonfl\u00e9e et chaude. \n\t\tToute mobilisation est impossible.\n\t\t Peau en regard rouge pivoine, luisante et tendue. \n\nEvolution \t- Pas de R/ \tdisparition sympto en 1 \u00e0 3 semaines \n\t- Avec R/ \ten 3-4j \n\tdesquamation peau en regard art  \n\tLe patient remarche et devient comple\u0300tement asymptomatique ... jusqu'a\u0300 la crise suivante. \n\nNB : PAS un syndrome articulaire douloureux chronique, \u00e0 l'exception des rares polyarthrites goutteuses. "}}, {"contentCard": {"Q": "Crise de goutte \nEpid\u00e9mio \nFacteurs d\u00e9clenchants", "A": "Ho +++ \nAge > 35 ans \ntendance familiale ! demander atcds familiaux\n\n- imbibit\u00b0 \u00e9thanolique aigu\u00eb (augm taux sanguins de lactate qui inh. s\u00e9cr\u00e9tion tubulaire des urates)\n- consommation excessive de purines exog\u00e8nes (thymus, rogons, riches en cellules), \n- traumatisme local, \n- geste chirurgical : jeune prolong\u00e9 -> augm lactate -> compet ac urique pr \u00e9limination\n- infection, \n- prise d\u2019un diur\u00e9tqiue\n- ++  la prise intempestive d\u2019un R/ hypouric\u00e9miant : allopurinal "}}, {"contentCard": {"Q": "Goutte \nDiagnostic", "A": "CLINIQUE +++ \n\nBIOLOGIE : \nEn crise :  pas r\u00e9ellement informatif\n- CRP et GB possiblement \u00e9lev\u00e9s \n- Uric\u00e9mie : NON poss. paradoxalement nle \n\t- par interf\u00e9rence m\u00e9dicamenteuse (les anti-infl peuvent faire baisser l'uric\u00e9mie), \n\t- ++ redistribution du pool d'urates (du sang vers art) \nDoser \u00e0 distance de la crise\n\nPCT ART -> EXAM MICROSCOPIQUE IMMEDIAT DU LIQ ART\n- Exsudat tr\u00e8s riche en cellule : ++ PMN neutrophiles\n- Cristaux intracellulaires (dans PMN neutrophiles) d'urate monosodique  = PREUVE FORMELLE\n\t= aiguilles r\u00e9guli\u00e8res bir\u00e9fringentes en lumi\u00e8re polaris\u00e9e\n\nNB : pct art goutteuse est parfois de\u0301licate - voire impossible - au niveau d'une MTP, mais \u00e9videmment plus ais\u00e9e au niveau d'un genou ou d'une cheville. \n\nRx: Bof\t- impotence fct : ne sait pas aller \u00e0 la radio \n\t- rien de visible pdt phase aigue\n\t- plusieurs crise au m\u00eame endroit pr avoir r\u00e9percussion osseuse\n\nSENSIBILITE A LA COLCHICINE ++ "}}, {"contentCard": {"Q": "Crise de goutte \nR/ ", "A": "- glace\n- d\u00e9charge\n- colchicine ou AINS\n- cortico\u00efdes si IR \n- infiltration intra arti glucort (pas ds js) efficace\n- PAS d'uricosurique ou uricofrainateurs ! \n\nPremi\u00e8re crises : COLCHICINE  \n\t1 mg d\u00e8s les premiers signes d\u2019arthrite, \n\t0.5 mg une heure plus tard \n\tet encore 0.5 mg une heure plus tard. \n- ES rare si respect de cette posologie :  diarrh\u00e9es. \n- colchico-sensibilit\u00e9 ++++ de la goutte ->  test diagnostic\n\tr\u00e9pondant \u00e9galement mais moins fort et moins vite : \n\t-  pseudo-goutte\n\t- tendinopathies \u00e0 l'hydroxyapatite  \n\t- arthrites de la fi\u00e8vre familiale m\u00e9diterran\u00e9enne\n- augm concentration par \tjus de pamplemousse\n\t\tmacrolides\n\nCrises ult\u00e9rieures : AINS \n- si ES digestifs de la colchicine \n-si diagnostic d'arthrite goutteuse bien \u00e9tabli. \n\n!! CI AINS et COLCHICINE dans IR \n\nCas difficile (CI Colchicine : IR s\u00e9v\u00e8re,..)  : GLUCORTICO\u00cfDES\n- forte dose (par ex. 32 mg de MedrolR) pendant quelques jours uniquement\n- en infiltration\n\nPAS d'uricosurique ou d'uricofreinateur pendant  : \n-  CRISE, \n- 15 PREMIERS JOURS suivant crise -> prot\u00e9ger patient avec dose pr\u00e9ventive de colchicine (e. 0,5 et 1 mg/j)\nau risque de mobiliser le pool d'urate monosodique et de provoquer ainsi de nouvelles crises de goutte. \n\nParadoxalement, l'allopurinol - parce qu'il est trop souvent prescrit intempestivement - est devenu de tous les m\u00e9dicaments le plus grand pourvoyeur d'arthrite goutteuse ! "}}, {"contentCard": {"Q": "Hyperuric\u00e9mie \nR/", "A": "Cible < 5-6mg/dl\nR/ \u00e0 vie -> probl\u00e8me d'adh\u00e9rence !! manque de compliance = seule cause d'\u00e9checth\u00e9rapeutique \n-> !! convaincre le patient\n\nHyperuric\u00e9mie asymptomatique :  ne pas R/ tout le monde ! SSI\n- atcd familiaux \n- atcd de crise de goutte \n- tendance g\u00e9n\u00e9rale de traiter plus pr\u00e9coc\u00e9ment qu\u2019auparavant, surtout depuis que aug du risque CV connue\n\nMESURES hYGIENO-DIETETIQUES \n- R\u00e9gime d\u00e9pourvu en purines (abats, riz de veau, gibiers, fruits de mer, rognons, foie, lentilles, etc.) viande, soda , bi\u00e8re\n\t- pas suffisant dans hyperuric\u00e9mies s\u00e9v\u00e8re car fait chuter que de 10 \u00e0 15 % max\n\t- ok pour mod\u00e9r\u00e9es \n- R\u00e9gime hypocalorique -> dim exc\u00e8s pond\u00e9ral pr corriger les anomalies m\u00e9taboliques associ\u00e9es.\n- Abstention d'\u00e9thanol (surtout d'imbibition aigu\u00eb) \n\nR/ DE FOND\nhyperuric\u00e9mie symptomatique  =  compliqu\u00e9e de \n- goutte \n- et/ou tophus \n- et/ou lithiases uratiques r\u00e9cidivantes)\nBut = \tnormaliser l'uric\u00e9mie (cible : 6 mg/dl ; 5 mg/dl en cas de goutte tophac\u00e9e) \n\t-> \u00e9viter complications de l'hyperuric\u00e9mie chronique (arthropathie goutteuse, tophus,  lithiases , IR) \n\n\nURICOSURIQUES\nFaibles : \n- probenecid \tbloque URAT-1\n- sartans \tint\u00e9ressant pr R/ HTA chez patient hyperuric\u00e9mique\n\nPatients goutteux uric\u00e9mie pas ok malgr\u00e9 R/ uricofreinateur \n- Lesinurad(Zurampic)  \tbloque URAT-1 \n\t\u00e0 associer \u00e0 l'allopurinol !!! \n\n\tES : Lithiases urinaires -> prudence\n\t- patients avec une uraturie \u00e9lev\u00e9e (> 800 mg/j), \n\t- a fortiori s\u2019ils ont souffert de lithiases urinaires (CI) \n\tPr\u00e9vention  : prise de Vichy -> alcalinisation des urines -> dim pr\u00e9cipitation\n\t\nURICOFREINATEURS : Inhibiteurs de la xanthine oxydase, \n- l\u2019allopurinol (Zyloric) \n- febuxostat (Adenuric) : \u00e0 pr\u00e9f\u00e9rer ds les IR s\u00e9v\u00e8re"}}, {"contentCard": {"Q": "Hyperuric\u00e9mie \nR/ allopurinol ", "A": "\nES : accidents immuno-allergiques s\u00e9v\u00e8res (lyell, DRESS) \n\nPr\u00e9caution : \n- m\u00e9tabolisation par xanthine oxydases : azathioprine ou de 6-mercaptopurine\n\t-> r\u00e9duire les doses en cas de traitement par allopurinol\n- potentialisation de l\u2019effet des anticoagulants coumariniques. \n\nPosologie : \nATTENDRE 15J apr\u00e8s crise de goutte sous pr\u00e9vention par colchicine, \n-> D\u00e9marrer R/ de fond en commen\u00e7ant PROGRESSIVEMENT par de petites doses ( ex. 50 mg d'allopurinol).\n\t(sinon risque pr\u00e9cipiter crise de goutte) \n\nAPRES 15J  : Dose X2  et adapter ensuite la posologie en fonction de l'uric\u00e9mie \n\t- majorit\u00e9 des patients :  ok 300 mg d'allopurinol\n\t- certains encore + !   \n\t- \u00f4 : Ok  100 mg. \n\nR/ Pr\u00e9ventif par colchicine (0,5 a\u0300 1 mg/jour) (ou par AINS) tant que la posologi pas stable SI \n- hyperuric\u00e9mie depuis longtps \n- tophus..\n- atcd crise de goutte"}}, {"contentCard": {"Q": "Tophus", "A": " = autre complication de l'hyperuric\u00e9mie \n = D\u00e9pots  d'urates intratissulaires. \n\nLocalisations \n- pavillon de l'oreille, \n- position juxta-articulaire ( ++  IPP , IPD , premi\u00e8re MTP) \n- bourses s\u00e9reuses\n- tendons (d'Achille notamment). \n\nNodules sous-cutan\u00e9s \n\t- indolores, \n\t- couleur blanc jaun\u00e2tre (typiquement chamois),\n\t-  possible ulc\u00e9ration -> \u00e9chappement bouillie crayeuse d'urate monosodique. \n\nComplication : arthropathie uratique chronique\n\t-  retrouv\u00e9 dans la membrane synoviale et dans les \u00e9piphyses osseuses.\n\t-  Rx : images g\u00e9odiques expansives, \u00e0 l'emporte-pi\u00e8ce\n\t\t destruction articulaire. \n\t- Clin : D+ m\u00e9caniques + chronique ET crises aigu\u00ebs"}}, {"contentCard": {"Q": "Complications r\u00e9nales ", "A": "= autre complication du l'hyperuric\u00e9mie \n\nLITHIASES RENALES\n- 10 \u00e0 20 % des goutteux ont souffert ou souffriront de lithiases r\u00e9nales. \n- FdR \t- forte hyperuric\u00e9mie (\u2265 13 mg/dl) \n\t- franchement hypers\u00e9cr\u00e9teurs. \n\n(IRA ANURIQUE) rare\n-  pr\u00e9cipitation massive de cristaux d'urate monosodique dans les voies excr\u00e9trices.\n- ds d\u00e9cours d'un traitement cytostatique prescrit pour leucose et justifie amplement des mesures pr\u00e9ventives (vide infra). \n\n(NEPHRITE INTERSTIELLE CHRONIQUE ET IRC) \ndu \u00e0 des d\u00e9pots d'urates dans l'interstitium r\u00e9nal \n(15 % des goutteux avec goutte tophac\u00e9e). "}}]}, {"name": "Chondrocalcinose et pseudo-goutte", "contentChapter": [{"id": 0, "contentCard": {"Q": "D\u00e9finition\nLocalisation\nDiag", "A": "Chondrocalcinose  = incrustation par des cristaux de pyrophosphate de calcium dihydrat\u00e9(PPCD). \n \t- des cartilages hyalins \n\t- et des fibrocartilages (m\u00e9nisques, disques intervert\u00e9braux) \n\nLocalisation : - au niveau de toutes les articulations \n\t-mais ++++\t- genoux  : cartilages f\u00e9moro-tibiaux et m\u00e9nisques\n\t\t- poignets  : ligament triangulaire du carpe\n\t\t- symphyse pubienne \n\nRx : d\u00e9p\u00f4ts de densit\u00e9 calcique, lin\u00e9aires ou finement perl\u00e9s \n\t-> Pose souvent le diag lors des crises de pseudo-goutte\n\t-> Pfs utile d'avoir radio de symphyse pubienne (accumulation \u00e0 cet endroit) \n\nPct articulaire pour pseudogoutte (voir fiche suivante)"}, "format": {"Q": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], "A": [["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []]}}, {"id": 1, "contentCard": {"Q": "Epid\u00e9miologie\nFdR", "A": "Pr\u00e9valence augmente avec l'\u00e2ge : \n- rare avant 50 ans, \n- 10 \u00e0 15 % dans la tranche 65-75 ans \n- 30 \u00e0 60 % au-del\u00e0 de 85 ans, \n\n++ F\u00ea \n\nFdR  : fr\u00e9quence de la chondrocalcinose accrue \n\t- HPP\n\t- h\u00e9mochromatose \n\t- hypomagn\u00e9s\u00e9mie chronique. "}}, {"id": 2, "contentCard": {"Q": "Clinique ", "A": "+++ ASYMPTO \n-> Sa d\u00e9couverte ne doit donc pas \u00e9garer le clinicien. \n\nARTHRITE MICROCRISTALLINE  = Pseudo-goutte (car ress ++ goutte)\nEtio : \tdissolution des cristaux de PPCD dans l'articulation \nLocalisat\u00b0 : \t++ genou , poignet\nDiag : \tPction art : cristaux de PPCD  = parall\u00e9logrammes de petite taille peu bir\u00e9fringents\n\t= EN FAVEUR (pas formel) \n\nARTHROPATHIE CHRONIQUE \n-  plus destructrice \n-  = arthrose secondaire \u00e9volutive (chondrocalcinose = FF ou aggravant) "}}, {"id": 3, "contentCard": {"Q": "R/ ", "A": "CRISE  : prescrire prudemment : P.ag\u00e9es \n- Glace \n-  anti-inflammatoires \n- colchicine est efficace, mais moins que dans la goutte. \n- infiltration cortico\u00efdes \n\nPAS DE R/ DE FOND  de la chondrocalcinose. "}}, {"id": 4, "contentCard": {"Q": "Diff\u00e9rence entre goutte et pseudo goutte", "A": "GOUTTE \t\tPSEUDO-GOUTTE\n\nd\u00e8s 40 ans \t\t> 60 ans\n\n1re MTP \t\tpas 1er MTP\ncheville \t\tgenou \ngenou \t\tpoignet\n\t\nhyperuric\u00e9mie\t\tnon \n\ncristaux d'urate \tcristaux de PPCD\nmonosodique \t\t\ntr\u00e8s bir\u00e9fringent \tpeu bir\u00e9fringent\n\nrien ou \u00e9rosions \tliser\u00e9 calcifi\u00e9 \t\n\u00e0 l'emporte-pi\u00e8ce \tfibro cartilage\n\nR/ hypo-uric\u00e9miants \tR/ inexistant"}}]}, {"name": "Polyarthrite rhumato\u00efde PR", "contentChapter": [{"id": 0, "contentCard": {"Q": "Epid\u00e9miologie , age, sexe", "A": "Maladie rhumatismale inflammatoire la plus fr\u00e9quente : pr\u00e9valence = 0,5 % \n78 000 pers en belgique\n\nAge : \t- ++ d\u00e9but 30-40 ans \n\t- mais aussi formes juv\u00e9niles ou d\u00e9buts tardifs (>60 ans )\n\n++ f\u00ea (4/1) "}}, {"contentCard": {"Q": "Etiologie \nFdR", "A": "Etiologie inconnue\n\n \nSusceptibilit\u00e9 g\u00e9n\u00e9tique :\n- haplotype HLA DR1/DR4 (75 % des PR) \n\nFacteurs exog\u00e8nes favorisant : \n- Tabac  : FF de l'apparition ET de l'aggravation de la PR\n- Parondotite chronique\n\nParticipation de lymphocyte Th17  \n-> Identification des m\u00e9diateurs cytokiniques\n-> Permet bioth\u00e9rapie  (voir physiopatho) "}, "format": {"Q": [[], [], [], [], [], [], [], [], [], [], [], [], [], []], "A": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []]}}, {"id": 1, "contentCard": {"Q": "Physiopathologie ", "A": "DISCUTEE\n\nmaladie de la membrane synoviale = 2 hypoth\u00e8ses\n- maladie primitivement immunitaire  :  car infiltration +++ cell inflammatoire\n- maladie des fibroblastes synoviaux avec une r\u00e9action inflammatoire et immunitaire secondaires.\n\nCommun aux 2 :  inflammation et hyperplasie synoviale  -> franges articulaires (synovite) \n- Palissade  = 4-5 lames de synoviocytes (fibroblastes) au lieu d'1\n- n\u00e9oangiogen\u00e8se ++ vx \n- cellules inflammatoires : macrophagique, neutrophilique, lymphocytaire\n\t\t (pr\u00e9dominance de lymphocytes T CD4), cell dendritiques, ..\n- prod de liq art inflammatoire : exsudat avec > 1000 GB\n- prod d'enzymes  prot\u00e9olytiques : ++ m\u00e9talloprot\u00e9inases collag\u00e9nase, ..\n\t\t -> destruct\u00b0 collag\u00e8ne, prot\u00e9ine\n+ chimiokines, interleukines (IL),  prostaglandines \n->  digestion et envahissement du cart. et de l'os sous-chondral, \nsouvent \u00e0 la JCT ENTRE CARTILAGE ET SYNOVIALE  : la ou la membrane rejoint articulation -> la synoviale rentre dans l'os = PANNUS (= tissu de granulation qui envahi l'os ! un peu comme une tumeur) \n\nLe pannus inflammatoire \n- \u00e9rode l'OS (EROSIONS MARGINALES): car situ\u00e9 \u00e0 la marge de l'articulation , jct\u00b0 cartilage-synoviale)\n\t-> d\u00e9crite en Rx \n- d\u00e9truit le CARTILAGE (CHONDROLYSE) ,  les ligaments et les tendons (par collag\u00e9nase, MMP ) \n\nUne des \u00e9tiologie a \u00e9t\u00e9 identifi\u00e9e :  Lymphocytes TH17 \n= un sous-type de lymph T CD4\nr\u00e9cemment incrimin\u00e9s dans la physiopatho de plusieurs maladies inflammatoires dont: \n\t-  les maladies intestinales (maladie de Crohn et colite ulc\u00e9reuse), \n\t- le psoriasis\n\t- la PR\n\nProduisent\t- IL17\n\t- TNF\u03b1 (Tumour Necrosis Factor)\n\t- IL6 \t-> d\u00e9vellopement anti IL6 r\u00e9cepteur\n\t- IL21. \n\nCes cytokines   (surtt TNF et IL6) \n-  stimulent la production par les fibroblastes synoviaux (synoviocytes) de \n\t- m\u00e9taloprot\u00e9inases matricielles (matrix metalloproteinases, MMP), \n\t\t- MMP3 \n\t\t- collag\u00e9nase -> dest os, cart\n\t- cyclooxyg\u00e9nase  COX2 \t-> prod PG -> D\u00e9v anti-inflammatoires\n\t- NO synthase\t-> VD = rougeur\n\t-> contribution r\u00e9act\u00b0 inflamm et destruct\u00b0 tissulaire\n\n- activent les lymphocytes B (jouent un r\u00f4le essentiel ds physiopatho de la PR) : \n\t-  production d\u2019autoAc : \tFR \n\t\t\tAnti-CCP : Ac anti-peptides cycliques citrullin\u00e9s \n\t- ++ cellules pr\u00e9sentatrices d\u2019antig\u00e8ne. \n\n-  augmentent l\u2019expression de RANKL sur les ost\u00e9oblastes, \n\t-> stimulat\u00b0 des ost\u00e9oclastes =  cell responsables in fine de la destruction du tissu osseux. "}, "format": {"Q": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], "A": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []]}}, {"contentCard": {"Q": "Diagnostic", "A": "Le diagnostic de la PR de\u0301butante est donc e\u0301minemment clinique et se\u0301rologique, comme le soulignent les crite\u0300res de classification propose\u0301s par l\u2019ACR/EULAR, re\u0301sume\u0301s dans le Tableau 25. Il faut se me\u0301fier d\u2019attribuer trop vite a\u0300 une \u00ab PR \u00bb des plaintes rhumatismales aspe\u0301cifiques, me\u0302me si le se\u0301rum du patient contient du facteur rhumatoi\u0308de. A l\u2019inverse, il faut savoir diagnostiquer pre\u0301cocement une PR de\u0301butante vraie, car l\u2019instauration pre\u0301coce d\u2019un traitement permet peut-e\u0302tre d\u2019e\u0301viter une e\u0301volution articulaire pe\u0301jorative. \n\nEssentiellemnt clinique\n- Diag PR d\u00e9butante pfs difficile qd plaintes d'apparition progressive \n\t\t\tou de fa\u00e7on intermittente. \n- Si la PR est le prototype des rhumatismes inflammatoires, \n\t!!! toute oligo- ou polysynovite ne doit pas lui \u00eatre syst\u00e9matiquement attribu\u00e9e. (Arthrose ++) \n\t-> Voir DD rhumatismes inflammatoire les + fr\u00e9quents : \t\n\t\n\t- infections \th\u00e9patites virales , EBV, CMV, parvovirus\n\t\tborr\u00e9liose \n\t\tstreptocoques , gonocoques \n\t- arthrites microcristallines  : goutte et chondrocalcinose \n\t- PR \n\t- spondyloarthrites \n\t- connectivites\n\t- vasculites \n\n- Un petit % souffre de maladie inflammatoire ! Important pour reconna\u00eetre = le rythme inflammatoire\n\nBiologie\nvoir fiche (CRP, FR, anti CCP) \n\nRadiologie Rx\nvoir fiche \n\nEchographie articulaire (musculo-squelettique)\nidentifie\n- Pr\u00e9sence d\u2019une quantit\u00e9 anle de liq art. (\u00e9chographie grey scale) \n\t- surtout si genoux un peu enrob\u00e9 on voit pas bien les gonflements ! \n- Signal Doppler (\u00e9chographie Doppler-couleur), signant l\u2019hypervascularisation. \n\tsignal doppler montre que PR tr\u00e8s active\n\nNON sp\u00e9cifique : aussi autres maladies rhumatismales inflammatoires. \n\n\n(PCT\u00b0 ARTICULAIRE :  )\tconfirmer la nature inflammatoire de l'arthropathie \n\t\tmais pas de faire le diagnostic de PR. "}, "format": {"Q": [[], [], [], [], [], [], [], [], [], []], "A": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []]}}, {"id": 2, "contentCard": {"Q": "Diagnostic \nClinique\nPr\u00e9sentations", "A": "POLY OU OLIGOARTHRITE (ou -synovite) DISTALE SYMETRIQUE  ++++ (majorit\u00e9 des cas) \nLocalisation sym\u00e9trique\t- poignets ++ \n\t\t- MCP \tsurtout la 2e et la 3e\n\t\t- IPP \tPAS les IPD (>< gonflement, d\u00e9format\u00b0 ++ Arthrose)\n\t\t- MTP \tSqueeze test +  = pincer les MTP\n\nPlainte articulaires de rythme inflammatoire : \nD +  \t inflammatoire\n\t+ marqu\u00e9e au r\u00e9veil\n\n+ Raideur \t- matinale prolong\u00e9e (pas 5 min , +ieurs h ! ) \n\t- att\u00e9nuat\u00b0 pendant la journ\u00e9e \n\t- r\u00e9apparit\u00b0 dans la soir\u00e9e et pendant la nuit. \n\nassoci\u00e9e \u00e0 : \nGonflement, sensibilit\u00e9 , enraidissement des articulations (plus rarement chaudes) \n\t- ++ Mains , poignets\n\t- si on ne voit rien (par ex au d\u00e9but) :  revenir + tard, photos pdt crise\n\t- IPP gonfl\u00e9e chez personne jeune ce n'est pas de l'arthrose !! \n\t- Liquide dans l'articulation (on sent une certaine r\u00e9sistance)\n\t\t>< Doigts gonfl\u00e9 : canal carpien, mange trop sel\n\t\t>< arthrose : nodules osseux\n\t\n! Il faut l'association des 2 pour faire le diag ! \n\nNB : Les gaines t\u00e9nosynoviales (extenseurs et fl\u00e9chisseurs des doigts) participent pr\u00e9cocement \u00e0 la r\u00e9action inflammatoire (car m\u00eame structure membranaire) \n\t-> accentue encore davantage, au niveau des doigts, \n\t\t- la limitation de la mobilit\u00e9 articulaire induite par l'arthrite elle-m\u00eame \n\t\t- la destruction des tissus (-> m\u00eame des tendons !) \nSi on fait une IRM de la main (pas en pratique) : signal liquide autour des articulations\n\t\t\t+ autour des tendons fl\u00e9chisseurs \n\nEXAMEN CLINIQUE\nPR d\u00e9butante : \n-  PAS de d\u00e9formations articulaires (< \u00e9volution chronique sur ann\u00e9es) \n- pr\u00e9sence d'une, de plusieurs ou de nombreuses arthrites et t\u00e9nosynovites\n\t-  D+  \u00e0 la pression des articulations (squeeze test + : pincer MTP) \n\t- Gonflement - souvent fusiforme au niveau des IPP \n\t- diminution de leur mobilit\u00e9 active et passive (impossibilit\u00e9 de fermer le poing) \n\t- r\u00e9duction de la force de pr\u00e9hension. \n\nAUTRES PRESENTATIONS : \n- polyarthrite f\u00e9brile d'apparition aigu\u00eb\n- monoarthrite d'une grosse articulation \u00e9voluant sur un mode subaigu voire chronique\n- rhumatisme rhizom\u00e9lique (= des racines des membres chez patients \u00e2g\u00e9s)\n- rhumatisme palindromique  = manifestations articulaires intermittentes mono- ou oligoarticulaires. \n\n"}, "format": {"Q": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], "A": [["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], ["u", "b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["r"], ["r"]]}}, {"contentCard": {"Q": "Variabilit\u00e9 \nEvolution \nFacteur d'\u00e9volution pr\u00e9jorative", "A": "Affecte chaque malade de fa\u00e7on diff\u00e9rente car \n-  le nombre, la topographie et la se\u00e9quence des articulations atteintes peuvent varier, \n- ++  l\u2019agressivit\u00e9 de la maladie est tr\u00e8s variable : \n\t- Certains d\u00e9truisent leurs articulations en quelques ann\u00e9es malgr\u00e9 R/ ad\u00e9quat \n\t- d\u2019autres,  indolent et peu \u00e9volutif \n\t- chez d\u2019autres encore, \u00e9volution par pouss\u00e9es, avec de longues p\u00e9riodes de r\u00e9mission. \n\nNous ne sommes pas encore capables de pre\u0301dire l\u2019\u00e9volutivit\u00e9 individuelle de la maladie rhumato\u00efde. \n\nFacteur d'\u00e9volution p\u00e9jorative : \n- caract\u00e8re franchement polyarticulaire d\u2019embl\u00e9e, \n- haplotype HLA DR1/DR4, \n- titre \u00e9lev\u00e9 de FR  \n-  signes extra-articulaires pr\u00e9coces, comme les nodules. \n! exceptions ++ \n\n"}}, {"contentCard": {"Q": "Diagnostic\nBiologie\n", "A": "Syndrome inflammatoire (CRP)\t\n- svt mais pas tjs\n- absence de sd infl n'exclut pas pr\u00e9sence d'une arthrite\n- SUIVI : diminue avec R/\n\nFacteur rhumato\u00efde (FR) \t\t\n- IgM anti-IgG  = auto anticorps\n- Diagnostic de la PR : \tPEU sensible  : que 70% des malades PR avec FR+ \n\t\tNON sp\u00e9cifique : voir DD pr\u00e9sence FR (P.ag\u00e9es,.. ) (++ FP) \n\t\t-> FR +  chez patient \"rhumatisant\" PAS bon argument en faveur du diag de PR. \n- Test = agglutination GR de mouton recouverts d'Ac\n\nAnticorps anti-CCP =  \n- anticorps anti-peptides citrullin\u00e9s = auto anticorps \n- facilite++ (r\u00e9volutionne) l\u2019identification des patients avec PR \n\t(du moins les formes s\u00e9ropositives) \n\t-> Des patients sont s\u00e9ron\u00e9gatifs : on ne connait pas encore leur Ac !\n- R\u00e9action inflammatoire dans la synoviale\n\t-> activation enzyme PAS(protein arginine deaminases). \n\t-> citrullination des prot\u00e9ines = convers\u00b0 r\u00e9sidus arginine en r\u00e9sidus citrulline = non sp\u00e9cifique de PR\n\t-> r\u00e9action auto-immunitaire contre prot\u00e9ines citrullin\u00e9es  = sp\u00e9cifique de la PR\n\t\tEtio : sans doute contexte HLA DR des patients PR\n- Test = ELISA avec citrulline (et non arginine) \n- sp\u00e9cifique :  Anti CCP + (en titre significatif) + Plaintes art. inflamm (D+ et raideur)+ Gonflement \n\t= Diag de PR \n\tNB : Anti CCP + et symp polyalgique = plus enclin a faire PR mais ne veut pas dire qu'elle en une\n- PEU sensible : que 70% des PR avec anti-CCP + (on loupe 30%) \n\n\n"}, "format": {"Q": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], "A": [["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], ["i"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []]}}, {"contentCard": {"Q": "Diagnostic\nBiologie \nDD des FR+   \n+ fr\u00e9quence du FR\n-> FR non sp\u00e9cifique de la PR", "A": "Avec l'\u00e2ge , si maladie inflammatoire ou infectieuse chonique , parasite\n-> Syst\u00e8me immunitaire fonctionne trop, trop stimul\u00e9\n-> Tendance \u00e0 faire auto-Ac \n\n- polyarthrite rhumatoide \t70 % -> FR non sensible\n- sujets sains, \u00e2g\u00e9s > 65 ans\t10 %\n\nMaladie inflammatoire chronique : \n- LED \t\t25% \n- Scl\u00e9rose syst\u00e9mique \t20% \n- dermatopolymyosite \t10 %\n- syndrome de Sj\u00f6gren \t85% \n\nMaladie infectieuse , parasite : \n- endocardite d'Osler \t30 \n- tuberculose \t\t10 \n- leishmaniose visc\u00e9rale \t90 \n- HCV, HIV,..\n\n- silicose \t\t20 \n- fibrose pulmonaire\t30\n- cirrhose   \t\t15 \n\n"}, "format": {"Q": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], "A": [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []]}}, {"contentCard": {"Q": "Diagnostic \nRx", "A": "STADES INITIAUX  :\nRien de visible sauf :  gonflement des tissus mous p\u00e9ri-articulaires (IPP, MCP , \n\t\t-> confirme la synovite \n\t\t-> n'affirme PAS sa nature.\n\nPLUSIEURS MOIS d'\u00e9volution clinique : \n-  rar\u00e9faction osseuse m\u00e9taphysaire en bande\n-  (pr\u00e9)-\u00e9rosions marginales : - 1\u00e8res \u00e9ros\u00b0 +++ au nv des t\u00eates m\u00e9tatarsiennes \n\t\t\t-> Exam radio soigneux des MTP \n\t\t - Absence n'exclut pas PR !!\n- chondrolyse sym\u00e9trique : cart devient + fin , r\u00e9gulier, un peu partout\n\t\tDD Arthrose : irr\u00e9gulier !"}, "format": {"Q": [[], [], [], [], [], [], [], [], [], [], [], [], [], []], "A": [["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], ["u"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], ["r"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], ["b"], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []]}}, {"id": 3, "contentCard": {"Q": "Complications articulaires", "A": "Si toutes les articulations peuvent virtuellement e\u0302tre atteintes par la PR, certains tableaux cliniques me\u0301ritent une description particulie\u0300re en raison de leur fre\u0301quence, de leur re\u0301percussion fonctionnelle ou de leur particularisme clinique. \nLa subluxation des MCP avec de\u0301viation cubitale (ou ulnaire) est caracte\u0301ristique. Sa pathoge\u0301nie est complexe et implique une traction pre\u0301fe\u0301rentielle des structures ligamentaires et tendineuses du co\u0302te\u0301 cubital. Au niveau des IPP, on peut noter une de\u0301formation en boutonnie\u0300re ou en col de cygne. La boutonnie\u0300re se caracte\u0301rise par une hyperflexion de l'IPP et une hyperextension de l'IPD. Elle re\u0301sulte d'une relaxation des bandelettes late\u0301rales des tendons extenseurs qui glissent ventralement : l'IPP est ainsi coince\u0301e en flexion entre les deux bandelettes late\u0301rales, comme un bouton dans une boutonnie\u0300re. La troisie\u0300me phalange - ou\u0300 s'inse\u0300rent les bandelettes - subit alors un maximum de contrainte d'extension. Le col de cygne repre\u0301sente la de\u0301formation inverse : hyperextension de l'IPP et hyperflexion de l'IPD. Elle re\u0301sulte d'un glissement dorsal des bandelettes late\u0301rales, ce qui favorise l'hyperextension de P2 sur P1. \nLes te\u0301nosynovites digitales enrichissent le tableau clinique de la main rhumatoi\u0308de. Au niveau des tendons fle\u0301chisseurs, les pathologies les plus fre\u0301quentes sont la te\u0301nosynovite inflammatoire e\u0301ventuellement cre\u0301pitante, le doigt a\u0300 ressaut et un syndrome du canal carpien secondaire. La complication la plus fre\u0301quente de la te\u0301nosynovite chronique des extenseurs est une tume\u0301faction de la face dorsale du poignet. La plus se\u0301ve\u0300re est la rupture tendineuse favorise\u0301e notamment par la subluxation ventrale du poignet et la proe\u0301minence de l'extre\u0301mite\u0301 distale du cubitus qui fragilise les extenseurs des quatrie\u0300mes et cinquie\u0300mes rayons digitaux. \nL'atteinte du poignet (carpite) est extre\u0302mement fre\u0301quente et peut se traduire rapidement par un de\u0301ficit d'extension et de flexion et plus tardivement par une subluxation ventrale du poignet responsable de la proe\u0301minence de l'extre\u0301mite\u0301 distale du cubitus (touche de piano). \nL'atteinte de l'avant-pied rhumatoi\u0308de est aussi fre\u0301quente qu'invalidante. Elle de\u0301bute par une synovite des MTP qui - en raison des douleurs palmaires a\u0300 l'appui qu'elle provoque - favorise un appui maximal sur les talons et une hyperextension des orteils qui contribue a\u0300 la subluxation des MTP. Les patients marchent alors sur leurs te\u0302tes me\u0301tatarsiennes en regard desquelles se forment des callosite\u0301s qui peuvent s'ulce\u0301rer et s'infecter. Leurs orteils se de\u0301saxent, se mettent en griffe ou se chevauchent l'un l'autre. \n109 \nLe gros orteil est souvent de\u0301vie\u0301 en valgus, re\u0301alisant typiquement l'avant-pied triangulaire de la PR. \nLa synovite rhumatoi\u0308de du genou peut e\u0302tre tre\u0300s exsudative et offre souvent au clinicien l'occasion de ve\u0301rifier le caracte\u0300re inflammatoire du liquide articulaire. Elle peut se compliquer d'un kyste poplite\u0301, de\u0301ja\u0300 discute\u0301 dans le cadre de la gonarthrose. \nLa PR e\u0301pargne le rachis, sauf la colonne cervicale. L'atteinte la plus typique est une subluxation atloi\u0308doaxoi\u0308dienne favorise\u0301e par la destruction - par la synovite rhumatoi\u0308de - du ligament transverse qui solidarise l'arc ante\u0301rieur de l'atlas a\u0300 l'apophyse odontoi\u0308de de l'axis. La combinaison - a\u0300 des degre\u0301s divers - d'une rupture ou d'une laxite\u0301 du ligament transverse et d'une e\u0301rosion de l'apophyse odontoi\u0308de permet le glissement vers l'avant de l'atlas sur l'axis, ce qui entrai\u0302ne une compression du cordon me\u0301dullaire. La distance (ou diastasis) entre la face poste\u0301rieure de l'arc ante\u0301rieur de l'atlas et la face ante\u0301rieure de la dent de l'axis ne de\u0301passe normalement pas 2,5 mm en flexion force\u0301e. Cette valeur est souvent de\u0301passe\u0301e chez les patients souffrant de PR. Au-dela\u0300 de 10 mm de diastasis atloi\u0308doaxoi\u0308dien en flexion, le risque de compression me\u0301dullaire augmente nettement, me\u0302me si la corre\u0301lation entre l'importance du diastasis radiologique et la symptomatologie clinique (syndrome pyramidal aux quatre membres) n'est pas parfaite. Dans les cas ou\u0300 une compression me\u0301dullaire est suspecte\u0301e, l'imagerie par re\u0301sonance magne\u0301tique nucle\u0301aire du rachis cervical est tre\u0300s utile. A co\u0302te\u0301 de la subluxation atloi\u0308doaxoi\u0308dienne, la PR peut provoquer des subluxations d'autres verte\u0300bres cervicales les unes par rapport aux autres ainsi qu'une invagination basilaire provoque\u0301e par l'ascension de l'odontoi\u0308de dans le trou occipital suite a\u0300 des remaniements oste\u0301oarticulaires de la base du cra\u0302ne secondaire a\u0300 une synovite chronique des articulations atloi\u0308do-occipitales. "}}, {"id": 4, "contentCard": {"Q": "Complications extra-articulaires", "A": "Les nodules sous-cutane\u0301s sont la complication extra-articulaire la plus fre\u0301quente puisqu'ils s'observent chez 20 % des patients, en ge\u0301ne\u0301ral se\u0301ve\u0300rement atteints et dont le se\u0301rum contient du facteur rhumatoi\u0308de. Les nodules apparaissent surtout aux points de pression, comme les faces dorsales des avant-bras (a\u0300 proximite\u0301 des coudes), aux doigts et aux tendons d'Achille. Leur consistance est ferme et ils adhe\u0300rent souvent au pe\u0301rioste sous-jacent. Histologiquement, on observe un centre ne\u0301crotique entoure\u0301 de cellules inflammatoires et de fibroblastes. Ils re\u0301sulteraient d'une re\u0301action inflammatoire et fibrosante autour d'une arte\u0301riole atteinte de vasculite avec ne\u0301crose fibrinoi\u0308de. Des nodules rhumatoi\u0308des visce\u0301raux ne sont pas exceptionnels, mais rarement symptomatiques. \n110 \nLes anomalies he\u0301matologiques sont fre\u0301quentes dans la PR, en particulier l'ane\u0301mie inflammatoire due a\u0300 une \"se\u0301questration\" du fer et probablement a\u0300 une diminution de la production de (et de la re\u0301ponse a\u0300) l'e\u0301rythropoi\u0308e\u0301tine. L'ane\u0301mie inflammatoire corre\u0300le souvent avec l'activite\u0301 clinique de l'affection. Il en va de me\u0302me de la thrombocytose, souvent observe\u0301e, mais dont la pathoge\u0301nie est largement inconnue. La leucope\u0301nie est rare dans la PR, sauf dans le syndrome de Felty qui associe une PR, une sple\u0301nome\u0301galie et une leuconeutrope\u0301nie parfois se\u0301ve\u0300re qui pre\u0301dispose aux infections bacte\u0301riennes re\u0301cidivantes. Ce syndrome apparai\u0302t en ge\u0301ne\u0301ral chez des patients souffrant d'une PR se\u0301ve\u0300re et ancienne, se\u0301ropositive et nodulaire. La sple\u0301nectomie est ge\u0301ne\u0301ralement efficace pour corriger la neutrope\u0301nie et pour e\u0301viter les complications septiques. Le tableau clinique peut s'enrichir d'ulce\u0300res ne\u0301crotiques des membres infe\u0301rieurs et d'une hypertension portale secondaire a\u0300 une hyperplasie nodulaire de\u0301ge\u0301ne\u0301rative. Il ne faut pas confondre le syndrome de Felty avec une leuce\u0301mie a\u0300 lymphocytes T granuleux (cellules NK) - encore appele\u0301e pseudo-Felty - qui complique rarement la PR et se traduit e\u0301galement par une sple\u0301nome\u0301galie et une neutrope\u0301nie. Dans ce cas, la recherche des marqueurs de membrane des cellules NK (en exce\u0300s) permet d'e\u0301voquer le diagnostic. \nLes complications pulmonaires de la PR sont rares mais varie\u0301es : pneumopathie interstitielle diffuse (UIP; usual interstitial pneumonia) complique\u0301e de fibrose interstitielle, nodule rhumatoi\u0308de, bronchiolite oblite\u0301rante, syndrome de Caplan (de\u0301veloppement d'une nodulose pulmonaire extensive chez des patients atteints de PR expose\u0301s a\u0300 la silice), pleure\u0301sie. Typiquement, l'e\u0301panchement pleural rhumatoi\u0308de contient essentiellement des lymphocytes et sa glycopleurie est infe\u0301rieure a\u0300 25 mg/dl en raison d'un de\u0301faut de transport du glucose a\u0300 travers la ple\u0300vre enflamme\u0301e. \nUne pe\u0301ricardite infraclinique est fre\u0301quente dans les PR se\u0301ve\u0300res, mais exceptionnellement constrictive ou complique\u0301e de tamponnade. \nDix a\u0300 35 % des patients atteints de PR souffrent d'un syndrome sec oculaire. Plus rarement, on observe une e\u0301piscle\u0301rite, une scle\u0301rite ou une scle\u0301romalacie perforante, souvent associe\u0301es aux formes se\u0301ve\u0300res de l'affection. \nLa vasculite rhumatoi\u0308de peut prendre deux formes : l'une, be\u0301nigne, se caracte\u0301rise par de petits infarcissements pe\u0301riungue\u0301aux; l'autre, maligne - on parle de PR maligne -, s'apparente aux vasculites syste\u0301miques ne\u0301crosantes (voir infra). Dans ces cas, on observe essentiellement des le\u0301sions ische\u0301miques, ulce\u0301ratives et ne\u0301crotiques des extre\u0301mite\u0301s et une polyneuropathie sensitivomotrice se\u0301ve\u0300re, voire des monone\u0301vrites \n111 \nmultiples, souvent dans un contexte de PR franchement nodulaire, e\u0301rosive et se\u0301ropositive et dans le cadre d'une importante alte\u0301ration de l'e\u0301tat ge\u0301ne\u0301ral. "}}]}]}, {"name": "Orthop\u00e9die-traumatologie", "contentCourse": [{"name": "Fracture", "contentChapter": []}, {"name": "FESF", "contentChapter": []}]}, {"name": "M\u00e9decine physique", "contentCourse": []}, {"name": "Radiologie", "contentCourse": []}, {"name": "Pharmacologie locomoteur", "contentCourse": [{"name": "Rhumatologie", "contentChapter": [{"id": 0, "contentCard": {"Q": "Vitamine D ", "A": "Forme active = Calcitriol = 1,25-dihydroxycholecalcif\u00e9rol = 1,23 (OH2) D3\n\nAgit via r\u00e9c intracellulaire VDR  sur organes cibles \n\neffet principal = stimule absorption calcium et phosphore \n\n\u00f4 effets \n- anti-prolif\u00e9ratifs\n- stimule immunit\u00e9 inn\u00e9e \n- inhibe auto-immunit\u00e9"}}]}]}, {"name": "Anapath", "contentCourse": []}]}}]}